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ABSTRACT  
Oxidative stress and dysfunction of potassium channels are believed to play a role in 
neuronal death in a number of CNS diseases (e.g. Alzheimer’s disease, epilepsy). 
The present study addresses selective neuronal vulnerability to oxidative stress by 
studying oxidative modulation of potassium channels in entorhinal cortex (EC) layer II 
stellate neurons (cell loss early in AD) and layer III pyramidal neurons (early damage in 
TLE), in comparison to hippocampal CA1 pyramidal neurons (late damage in TLE and 
AD). Using whole-cell patch-clamp, differential inhibition of transient IA and delayed 
rectifier K+-currents IK(V) by arachidonic acid (AA) and H2O2 was demonstrated. 
Intracellular AA (1 pM) reduced IA in EC neurons significantly stronger than in CA1 
neurons. AA affected the voltage dependence of steady-state inactivation as well. ETYA 
mimicked the effect of AA, excluding its metabolites as mediators of IA modulation. 
Neither AA nor ETYA reduced IK(V). In contrast, a non-lipid oxidizing agent, H2O2 reduced 
IA more effectively and robustly attenuated IK(V) in CA1, compared to EC neurons. AA-
mediated reduction of IA was blocked by free radical scavengers (glutathione, ascorbic 
acid, Trolox). 
Antioxidants did not simply inhibit AA and H2O2 effects. In particular, they even 
enhanced AA effects, suggesting more complex modulation of these currents in slices, 
compared to culture. Moreover, intracellular antioxidants, themselves, influenced 
maximal conductance and voltage-conductance characteristics of IA and IK(V). This should 
be considered in design of anti-oxidative therapies in AD and TLE. 
Heterologous expression of Kv1.4 and of Kv4.2 cDNA in HEK-293 cells formed functional 
channels and elicited A-type currents, which shared similar biophysical characteristics 
with native IA from the hippocampus. These currents were strongly decreased upon 
administration of 1pM AA, demonstrating that at least one of multiple sites for AA action 
is situated on the pore-forming alfa-subunit of the A-channel. 
In conclusion, beside contribution to cell damage, ROS may regulate physiological 
processes by acting on different signalling pathways. Since voltage-gated K+-channels 
underlie many important cellular functions modulation of these channels by ROS would 
represent a mechanism for fine tuning of cellular processes. 
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ZUSAMMENFASSUNG 
Der neuronale Zelluntergang bei einer Vielzahl von Krankheiten des ZNS, wie z.B. 
Morbus Alzheimer (AD) und Temporallappenepilepsie (TLE), wird mit oxidativem Stress 
sowie Fehlfunktionen von Kaliumkanälen in Verbindung gebracht. In dieser Studie soll 
die selektive neuronale Sensitivität auf oxidativen Stress durch die Messung der 
oxidativen Modulation von Kaliumströmen untersucht werden. Dabei werden 
sternförmige Neuronen der zweiten Schicht des entorhinalen Kortex (EC) (bei AD bereits 
früh geschädigt) mit pyramidalen Neuronen der dritten Schicht des EC (früh geschädigt 
bei TLE) sowie hippocampalen pyramidalen Neuronen der CA1 Region (bei AD und TLE 
erst spät geschädigt) miteinander verglichen.  
Mittels patch-clamp Ganzzellmessung zeigt diese Studie die differentielle Hemmung 
spannungsabhängiger transienter (IA) und „delayed-rectifier“ K+-Ströme (IK(V)) durch 
Arachidonsäure (AA) und Wasserstoffperoxid (H2O2). Die intrazelluläre Applikation von 
AA (1 pM) reduzierte IA in Neuronen des entorhinalen Kortex signifikant stärker 
verglichen mit Neuronen des CA1.  
ETYA imitiert diesen Effekt, dies schliesst die Metabolite der AA als Mediatoren des 
Effekts auf Kaliumkanäle aus. Weder AA noch ETYA reduzierten IK(V). Im Gegensatz dazu 
reduzierte H2O2 IA in Neuronen des CA1 effektiver als in Neuronen der Schichten II und 
III des entorhinalen Kortex. Die Reduktion des IA, vermittelt durch AA, wurde durch 
Radikalfänger (Glutathion, Ascorbinsäure, Vitamin E Analogon Trolox) blockiert. Dabei 
verstärkten manche dieser Antioxidantien den Effekt der AA, dies legt eine komplexere 
Modulation dieser Ströme in Schnitten verglichen mit Kulturen nahe. Dies sollte bei der 
Entwicklung antioxidativer Therapien von AD und TLE berücksichtigt werden. 
Bei der heterologer Expression von Kv1.4 und Kv4.2 in HEK-293 Zellen wurden 
funktionelle Kanäle gebildet und A-Typ Ströme ausgelöst. Diese Ströme wurden nach der 
Applikation von 1 pM AA stark reduziert. 
ROS scheinen neben ihrer zellschädigenden Wirkung physiologische Prozesse zu 
regulieren, indem sie eine Reihe von Signalwegen beeinflussen. Da spannungsabhängige 
Kaliumkanäle vielen wichtigen zellulären Funktionen zugrundeliegen, könnte die 
Modulation dieser Kanäle durch ROS einen Mechanismus für die Feinabstimmung 
zellulärer Prozesse darstellen. 
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INTRODUCTION 
Voltage-gated potassium currents 
Voltage-gated potassium currents were among the first membrane currents to be recognized 
and investigated for their important roles in neuronal signaling, particularly in the 
repolarization of the action potential (Hodgkin and Huxley, 1952). The first K+-current 
characterized by Hodgkin and Huxley was termed delayed rectifier to describe kinetic that is 
characterized by delayed onset of activation (compared to the sodium current), followed by 
little or no inactivation, and outward rectification, i.e. a deviation from the linear current-
voltage relationship of Ohm’s law.  
Almost 20 years later a second type of voltage gated K+-current has been detected: the 
transient A-current (IA) presents with rapid, transient activation in the subthreshold range of 
membrane potentials (-60 mV to -45 mV), fast inactivation, and fast recovery from 
inactivation (Connor and Stevens, 1971; Neher, 1971). These features suggest strong 
contribution to action potential or spike repolarization, and contribute to the regulation of the 
frequency of the repetitive firing (Baxter and Byrne, 1991; Connor and Stevens, 1971; Hille, 
1992; Liss and Roeper, 2001; Rudy, 1988). IA contributes also to the resting membrane 
potential (RMP) by the so-called window current (an overlap in the voltage range of current 
activation and inactivation), and therefore IA-channels exert a strong influence on steady state 
inactivation of Na+-channels. Thereby the A-current plays an important role in the signal 
processing in the dendrites, including the integration of the synaptic inputs, the filtering of 
fast synaptic potentials, the temporal regulation of action potential back-propagation from the 
soma into the dendrite, that is important for the induction of long-term potentiation by its 
voltage effect on Ca2+-permeation through NMDA receptors (Hoffman et al., 1997; Johnston 
et al., 2000; Schoppa and Westbrook, 1999; Watanabe et al., 2002). Influencing action 
potential duration, IA-channels strongly affect presynaptic Ca2+-influx and transmitter release 
(Pongs, 1999), affecting synaptic and network excitability (Muller and Misgeld, 1990; Muller 
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and Misgeld, 1991). The importance of the somatodendritic A-current in regulating firing 
frequency was recently highlighted by the demonstration that the pacemaker activity of 
individual dopaminergic neurons in the substantia nigra, and hence the level of dopamine 
release, is directly correlated with the density of the A-current (Liss and Roeper, 2001). For 
the investigation of function of those and other K+-currents (leak, Ca2+-dependent, etc.), 
availability of specific blockers (TEA, 4-AP, Cs+, dendrotoxin, charibdotoxin etc.) was 
crucial. 
 
Molecular basis of voltage-gated potassium currents  
Fast development of molecular biology, cloning and expression of K+-channels in the past 20 
years made possible a better understanding of K+-channel physiology and pathophysiology. 
These studies have demonstrated that potassium channels constitute a very diverse subfamily 
of ion channels and are composed of variable combinations of subunits encoded in large 
multigene families. The Kv family of genes encodes subunits of tetrameric voltage-gated 
potassium channels and is divided into several subfamilies, based on sequence similarities and 
evolutionary relationship (Coetzee et al., 1999; Cooper et al., 1998; Hille, 1992; Jan and Jan, 
1990; Pongs, 1992; Pongs, 1999; Rudy, 1988). This diversity contributes to the ability of 
specific neurons to respond uniquely to different inputs. Most of the cloned voltage-dependent 
channels appear to be members of four gene families. Simultaneous research on drosophila 
and rat resulted in two nomenclatures: voltage-gated potassium channel families can be 
identified by their Drosophila gene homologue (Shaker, Shab, Shaw and Shal) or by an 
alternative nomenclature (Kv1, Kv2, Kv3 and Kv4) (Wei et al., 1990). This classification has 
physiological consequences, because different subunits of the same family could combine to 
form functional tetrameric channel (Covarrubias et al., 1991; Salkoff et al., 1992). 
Among Kv-α-subunit genes that encode the transient outward Kv channels (IA) are Kv1.4, 
Kv3.3, Kv3.4, Kv4.1, Kv4.2 and Kv4.3. 
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Principal subunits 
Kv4.2 
Kv4.2 (KCND2, Shal family) protein is strongly expressed across the somatodendritic axis of 
hippocampal CA1 pyramidal neurons (Maletic-Savatic et al., 1995; Sheng et al., 1992), and 
evidence suggests that the predominant A-type transient current throughout principal neurons 
of the CNS arises from channels formed by Kv4.2 (Serodio et al., 1994). By Northern blot 
analysis, (Isbrandt et al., 2000; Zhu et al., 1999) expression of a 6.8-kb transcript was detected 
only in brain, particularly in the amygdala, caudate nucleus, cerebellum, hippocampus, 
substantia nigra, and thalamus. Heterologous expression determined that KCND2 mediates 
the rapidly inactivating, A-type outward potassium current which is not under the control of 
the N-terminus as it is in Kv1 (Shaker) channels (Zhu et al., 1999). The somatodendritic A-
type (Kv4.2) channels rapidly inactivate close to the action potential firing threshold and 
recover from inactivation in the millisecond time range (Pak et al., 1991; Serodio et al., 1994). 
In 2001, Bähring and co-workers suggested that Kv4.2 channels in response to membrane 
depolarization accumulate in the closed-inactivated state, from which they directly recover, 
bypassing the open state (Bahring et al., 2001). These features distinguish somatodendritic 
from other A-type channels. 
Pharmacologically, this channel is blocked in a dose-dependent manner by 4-amino pyridine 
(4-AP) and polyunsaturated fatty acids (PUFA), such as arachidonic acid (AA). The 
effectiveness of PUFAs, however, is dependent on the gene subfamily that encodes the 
channel. For example, AA is most efficient in blocking Shal (Kv4) channels, whereas for 
Shaker (Kv1) channels there are controversial findings (Danthi et al., 2003; Villarroel and 
Schwarz, 1996).  
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Kv1.4 
Channels from Kv1 (KNCA, Shaker) subfamily, for instance Kv1.4, also contributes to 
somatic transient currents in hippocampal basket interneurons (Zhang and McBain, 1995) and 
other neurons (Eder et al., 1996; Pardo et al., 1992). Moreover, there is evidence for 
heteromultimerization of Kv α-subunits from the same subfamily. It has been shown that 
antibodies, specific to Kv1.4 co-immunoprecipitate Kv1.2 and Kv1.1 proteins in non-
denaturated brain membrane extracts (Sheng et al., 1993). The co-expression of Kv1.4 and 
Kv1.2 in axons and terminals of many cells suggests the native A-type K+ current may result 
from Kv1.4/Kv1.2 heteromultimers within these compartments (Sheng et al., 1993; Wang et 
al., 1999). Such heteromultimere channels will exhibit hybrid pharmacology, for example to 
TEA. Therefore, there are not enough high-affinity pharmacological tools available for Kv1.4 
channels. 
Kv1 transient currents inactivate with time constants that change with the voltage and recover 
from inactivation very slowly (Po et al., 1993; Stuhmer et al., 1989). The inactivation 
mechanism of Kv1.4 is well understood and could be described as a ‘ball-and-chain’ 
interaction (Hoshi et al., 1990; Hoshi et al., 1991). In case of Kv1.4 channel, inactivation 
domain of the N-terminal of the Kv-α subunit (Zagotta et al., 1990) or of an accessory Kvβ 
subunit (Rettig et al., 1994) binds to a ball receptor near the inner entrance of the pore (Isacoff 
et al., 1991) thereby preventing ion flux through the open channel. The fast N-type 
inactivation of the Shaker channels is followed by a slower C-type inactivation, from which 
the channels recover slowly (Hoshi et al., 1990). 
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Regulatory subunits of Kv4.2 and Kv1.4 
A number of proteins have been discovered recently that have been shown to interact with and 
modify function of Kv-α proteins, including β-subunits (Kvβs), K+-channel Interacting 
Proteins (KChIPs), dipeptidyl aminopeptidase-like proteins (DPPX or DPP10), frequenin, 
postsynaptic density protein 95 (PSD95), filamin, etc. The physiological role of many of these 
proteins in native channels remains to be clarified. 
β-subunits 
Kvβ-subunits are proteins that are essential components of the Kv1 subfamily of voltage-
gated potassium channels and are non-enzymatic homologues of aldo-keto reductases 
(Campomanes et al., 2002; Gulbis et al., 1999; McCormack and McCormack, 1994). 
Transient K+ channels, formed by Kv1.4 proteins (and by other Kv1 α-subunits), complex 
with β-subunits that confer fast inactivation to otherwise non-inactivating Kv1 channels 
(Heinemann et al., 1996; Rettig et al., 1994). Furthermore, in this case, interaction of Kv1 
with beta subunits slows down the recovery from inactivation (Heinemann et al., 1995; 
Heinemann et al., 1996; Serodio et al., 1996). 
Another role assigned to the β-subunits is to act as chaperones during channel biosynthesis 
(Shi et al., 1996) and thus to increase expression levels, an effect first described for the 
interaction of Kvβ2 with Kv1.4 (McCormack et al., 1995).  
K+-channel Interacting Proteins (KChIPs) 
Potassium channel interacting proteins (KChIPs) were found to co-immunoprecipitate and co-
immunolocalize with Kv4 α-subunits in brain and heart (An et al., 2000). All KChIP subunits 
possess a high sequence homology region to neuronal calcium sensor-1 (NCS-1; frequenin) 
and calsenilin/DREAM, which belong to the superfamily of EF-hand-containing proteins. 
Therefore, a role for cytoplasmic calcium in the regulation of Kv4 channel function has been 
suggested (An et al., 2000; Weiss and Burgoyne, 2001). 
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 It has been demonstrated that frequenin itself is responsible for a Ca2+-dependent 
enhancement of Kv4 expression and modulation of kinetic behaviour (Nakamura et al., 2001). 
In agreement, KChIPs interact with NH2 terminus of Kv4 proteins and enhance surface 
expression, thereby increasing IA current densities when expressed in heterologous systems 
and in native tissues (An et al., 2000; Hatano et al., 2002; Liss and Roeper, 2001). For 
example, KChIP4a delays channel opening, but when the channel opens, it favours its open 
state by disrupting fast inactivation and slowing channel closing (Holmqvist et al., 2002). In 
contrast, KChIP1 speeds up inactivation from closed state and accelerates channel closing 
(Beck et al., 2002). Coexpression of KChIP1 in oocytes and mammalian cells results in 
increased current densities, slowed onset of inactivation, and accelerated recovery from 
inactivation (Nakamura et al., 2001; Hatano et al, 2002). Moreover, it has been shown that a 
defect in the KChIP2 gene results in complete loss of transient outward current (Ito) in cardiac 
myocytes (Kuo et al., 2001). 
Postsynaptic density protein (PSD-95) 
PSD-95, a scaffolding synapse-associated protein that possesses PDZ domains, associates 
with Kv4.2 and Kv1.4. It has been shown that PSD-95 influences Kv1.4 channel clustering 
(Hsueh and Sheng, 1998) and Kv4.2 channel surface expression without affecting total 
channel levels (Wong et al., 2002). 
Dipeptidyl peptidase-like protein (DPPX) 
DPPX (also known as DPP6 or BSPL) is a glycoprotein that is structurally related to the 
dipeptidyl aminopeptidase and cell adhesion protein CD26, but with unknown function. 
DPPX is co-expressed with the principal subunits of IA-Kv4 in a somatodendritic pattern in 
central nervous system (CNS) neurons. DPPX associates with the pore-forming subunit Kv4 
and drastically increases their intracellular trafficking and membrane targeting (Nadal et al., 
2003). 
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 Moreover, function reconstitution experiments in Xenopus oocytes and CHO cells 
demonstrated that DPPX increases the rate of inactivation of Kv4.2 currents, considerably 
decreases time to peak, shifts the voltage-dependence of both activation and steady-state 
inactivation to the left and also increases the rate of recovery from inactivation (Nadal et al., 
2003). 
 
Molecular basis of IK(V) 
Several candidate genes exist for being the molecular determinants of the delayed rectifier 
potassium current in pyramidal neurons. Among them are Kv2.1, Kv2.2 and Kv1.1 (Blaine 
and Ribera, 2001). This non-inactivating potassium current, known also as sustained 
potassium current, plays a major role in membrane repolarization during an action potential. 
Kv2 family is widespread throughout the CNS and in hippocampus, is localised on somata 
and dendrites of pyramidal cells and interneurones. Pharmacologically the delayed rectifier 
currents are sensitive to TEA and to high concentrations of 4-AP. 
 
Structure of a Kv channel 
After the cloning and expression of Kv-channel proteins it became possible to study the 
structure of Kv channels after cristallization and x-ray crystallography of the channel proteins. 
Kv potassium channels are tetramers and their monomers contain six transmembrane α-helical 
segments (S1-S6). An intramembrane loop between S5 and S6 (P-loop) possess specific 
sequence of amino acids that are responsible for potassium ions selectivity. Four subunits of 
voltage-gated potassium channel form the pore surrounded by integral membrane domains 
that can "sense" membrane voltage and open the pore in response to its change. 
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 The "voltage sensor" (S4) features positively charged arginine residues, that enable it to 
move at the protein-lipid interface, within the membrane electric field, thereby allowing 
membrane voltage to drive the pore between closed and opened states (MacKinnon, 2003). 
Both, N- and C-termini are in the cytosol and play an essential role in inactivation of the 
channels, as well as in regulatory subunits binding. 
 
 
 
Fig. 1 Membrane topology of a voltage gated potassium channel. 
Scheme of a Kv monomer. The six tansmembrane segments are shown in yellow (S1-6). A T1 
recognition domain is indicated in green. Charges (+ and -) are indicated for some of the residues in 
the transmembrane domains of the voltage sensor (S1-4). The pore region includes S5-S6 
intermembrane loop (Deutsch, 2003). Inset: Macrocomplex of Kv channel assemble with auxiliary 
subunits (dark blue). T1 domains associate with beta subunits. For simplicity the C termini are not 
shown. (Gulbis et al., 2000).  
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Arachidonic Acid 
“The arachidonic acid cascade is arguably the most elaborated signaling system 
neurobiologists have to deal with”-D. Piomelli (Piomelli, 1993). It not only generates multiple 
messenger molecules (~ 20, an estimate limited to the brain), but these molecules may act 
both within and from the outside of neurons, aiming at intracellular as well as extracellular 
targets. 
 
Arachidonic acid structure 
Arachidonic acid (AA) is a polyunsaturated fatty acid (PUFA) consisting of a 20-atom-long 
carbon chain with 4 double bonds and a carboxylic group at one of the ends (20:4). The 
carbon-carbon double bonds in AA and other polyunsaturated fatty acids can lead to free-
radical formation. Reactions with oxygen form unstable lipid peroxide compounds containing 
the same unstable oxygen-oxygen bond found in hydrogen peroxide and thus contributes to 
cellular oxidative stress. ETYA is a structural analogue of AA with chemically more stable 
triple bonds instead of double bonds (Fig. 2B). 
 
Fig. 2 Structure of arachidonic acid and ETYA 
 
 10
Arachidonic acid release  
In neurons, a receptor-dependent event, leading to Ca2+-influx or release of Ca2+ from 
intracellular stores, is required for the brain lipases to release arachidonate from the 
phospholipids of the cell membrane. Several neuromodulators stimulate the deacylation of 
membrane phospholipids, causing release of free arachidonate. These include excitatory 
amino acids (e.g. glutamate), biogenic amines (e.g. serotonin and histamine), and peptides 
(e.g. bradykinin). Even though the final effect of these various substances on arachidonate 
turnover is similar, they may use different mechanisms to achieve it.  
At least three distinct phospholipases are thought to generate free arachidonic acid, either 
directly (PLA2) or indirectly (PLC and PLD). A number of studies have shown that all 
phospholipases are activated by neurotransmitters. Previous reports indicate that the key 
enzyme responsible for agonist-induced AA release is cytosolic PLA2 (cPLA2) (Lin et al., 
1992; Roshak et al., 1994). cPLA2 is a cytosolic 85-kDa Ca2+-dependent phospholipase and is 
activated by both an increase in intracellular free Ca2+-concentration ([Ca2+-]i) and Ser-505 
phosphorylation by mitogen-activated protein kinase (MAPK) or protein kinase C (Leslie, 
1997). Hormones and growth factors also regulate PLA2 activity (Loo et al., 1997, Leslie, 
2004; Trevisi et al., 2002). In addition, H2O2 dose-dependently enhances cell membrane 
associated PLA2 activity and stimulates AA-release (Chakraborti and Michael, 1993; Yasuda 
et al., 1999). It was also suggested that H2O2 stimulates PLA2 through PKC (Chakraborti and 
Michael, 1993). 
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Fig. 3 Simplified scheme of arachidonic acid release events. IP3, inositol triphosphate, 
PLC, phospholipase C, PLA2 phospholipase A2, MAG, monoacyl glycerol DAG, 
diacylglycerol G, GTP-coupled protein, PIP2, phosphoinositol biphosphate 
 
Most researchers believe that a G protein ensures the coupling of receptors with PLA2. 
Jelsema and Axelrod (Jelsema and Axelrod, 1987), have first to demonstrate inhibition of 
PLA2 by G proteins. 
 
Arachidonic acid metabolism  
The major pathways of arachidonic acid metabolism have been discovered in most animal 
tissues, including brain. This pathways are controlled by lipoxygenase (LOX), 
cyclooxygenase (COX), and cytochrome (Cyt) P450 (Fig.4; Nishiyama et al., 1992; 
Nishiyama et al., 1993). AA is converted into a large number of biologically active 
metabolites such as leukotrienes, lipoxins, prostaglandins, and thromboxanes, termed with the 
common name eicosanoids. These metabolites seem to play significant roles in several 
important processes, including vascular contraction and cell growth (Anderson et al., 1997; 
Gong et al., 1995). 
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 In the brain, for example, 12-lipoxygenase products were shown to inhibit glutamate release 
from hippocampal mossy fiber nerve endings (Freeman et al., 1991), whereas 5-lipoxygenase 
metabolites were found to increase the activity of muscarine-inactivated M-K+ channels in rat 
hippocampal CA1 neurons (Schweitzer et al., 1990). Some lipoxygenase metabolites of AA 
also activate the cardiac, muscarinic-activated K+ channel, stimulate BKCa channels in rat 
pituitary tumor cells (Duerson et al., 1996), and modulate S-type K+ channels in Aplysia 
(Piomelli et al., 1987). K+ channel modulation by lipoxygenase products has also been 
reported in a number of non-neural cells, including heart myocytes (Kim and Duff, 1990). 12-
Hydroxyeicosatetraenoic acid (12-HETE) is a neuromodulator that is synthesized during 
ischemia. Its neuronal effects include attenuation of calcium influx and glutamate release as 
well as inhibition of AMPA receptor (AMPA-R) activation. 12-HETE reduces ischemic injury 
in the heart, but it can also reduce neuronal excitotoxicity. 12-HETE could protect neurons 
from excitotoxicity by activating a Gi/o-protein-coupled receptor, which limits calcium influx 
through voltage-gated channels (Hampson and Grimaldi, 2002).  
Arachidonic acid
LOX COX Cyt P450
prostaglandinsHPETE EETs
prostacyclins
thromboxanes
Lipoxins
Leukotrienes
HETE
Hepoxilins
 
Fig. 4 Simplified scheme of arachidonic acid metabolism. LOX, lipooxigenase; COX, cyclo-
oxigenase; CytP450, cytochrome; HPETE, hydroperoxyeicosatrienols, HETE, 
hydroxyleicosatrienols; EETs, epoxyeicosatrienoics 
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The eicosanoids produce a wide range of biological effects on inflammatory responses, on the 
intensity and duration of pain and fever (Samad et al., 2001; Vane, 1976), and on reproductive 
function (Zahradnik et al., 1992). Eicosanoids also play important roles in acid secretion 
(Eberhart and Dubois, 1995), regulating blood pressure through vasodilation (Pomposiello et 
al., 2001) or vasoconstriction (Yu et al., 2003), and inhibiting (Petroni et al., 1995) or 
activating (Davi et al., 1999) platelet aggregation and thrombosis.  
Modulation of voltage-gated potassium channels by arachidonic acid 
AA and its metabolic products have been shown to modulate a large number of ligand- and 
voltage-gated ion channels in a variety of systems (Bevan and Wood, 1987; Ordway et al., 
1991). The potential role of arachidonic acid in mediating K+-channel modulation and 
presynaptic inhibition of neurotransmitter release-one example of a second messenger role for 
the eicosanoids-was first suggested by J. Schwartz , based on experiments with Aplysia. AA 
has been shown to activate a large conductance (160 pS) K+-channel directly in cardiac atrial 
muscle (Kim and Clapham, 1989) and a small conductance (23 pS) K+-channel in smooth 
muscle (Ordway et al., 1991). In central neurons, AA either depresses or enhances K+-currents 
through lipoxygenase or cyclooxygenase metabolites (Keyser and Alger, 1990; Schweitzer et 
al., 1990; Zona et al., 1993). With respect to K+-channels in expression systems, AA has been 
shown to inhibit currents directly through channels formed by members of the Kv4 (Shal) 
subfamily of voltage-dependent potassium channels, whereas other members of Kv1 (Shaker) 
subfamilies were relatively insensitive to AA (Villarroel and Schwarz, 1996). 
High concentrations of arachidonic acid (≥1µM) directly modulate IA in CA1 hippocampal 
neurons (Colbert and Pan, 1999; Keros and McBain, 1997). Bittner and Müller showed that 
intracellular AA is highly potent in selectively inhibiting the A-current in cultured 
hippocampal neurons. Our group recently demonstrated, that extremely low concentration of 
AA (1 pM) attenuates IA, but not the delayed rectifier, in CA1 pyramidal neurons from acute 
brain slices (Angelova and Muller, 2006). 
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Oxidative Stress 
Cells constantly generate reactive oxygen species (ROS) during aerobic metabolism. ROS are 
produced as by-products of oxidative metabolism, in which energy activation and electron 
reduction are involved. Bearing an unpaired electron, these molecules can react with a large 
number of neuronal targets, beginning chain reactions that generate different radical species 
as intermediate products.  
ROS include free radicals such as the superoxide anion (O2-), hydroxyl radicals (·OH), and the 
non-radical hydrogen peroxide (H2O2). They are particularly transient species due to their 
high chemical reactivity and can react with DNA and proteins, i.e. enzymes, ion channels and 
lipids. Lipid peroxidation represents a chain reaction that results in massive oxidation of 
membrane lipids. ROS production is enhanced severely in several disease states such as 
hypertension, diabetes mellitus and atherosclerosis, but also during epileptic seizures (Kovacs 
et al, 2002). 
The high metabolic rate of neurons implies a high baseline ROS production. 
Correspondingly, healthy brain cells possess high concentrations of both enzymatic and small 
molecule antioxidant defenses. 
 
Antioxidants 
To counteract the effects of oxidative stress, cells have developed two important defense 
mechanisms: a thiol reducing buffer (GSH and thioredoxin), and enzymatic systems (SOD, 
catalase, and glutathione peroxidase). The most important thiol is the cellular redox buffer 
GSH, present within cells at a millimolar concentration. Thiols also exist in different cysteine-
containing compounds such as amino acids (cysteine, taurine, homocysteine), peptides (GSH, 
Coenzyme A), and proteins (thioredoxin, glutaredoxin, albumin, glutathione peroxidase, 
peroxiredoxin, redox factor-1, heat shock protein, etc). 
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 Additionally, thiol groups located on various molecules act as redox sensitive switches, 
thereby providing a common trigger for a variety of radical-mediated signalling events. 
Glutathione (GSH) 
The GSH system is probably the most important cellular defense mechanism that exists in the 
cell. The tripeptide GSH (Glu-Cys-Gly) not only acts as free radical scavenger but also 
functions in the regulation of the intracellular redox state. Recycling of the oxidized disulfide 
form (GSSG, Fig.5 A) maintains adequate levels of the reduced form of gluthathione (GSH, 
Fig.5 B). The system consists of GSH, glutathione peroxidase (GPx) and glutathione 
reductase. GPx catalyses the reduction of ROS and converts GSH to GSSG. GSSG is then 
reduced back to GSH by glutathione reductase that, in turn, is recycled by NAD+. GSH 
substrates include, but are not limited to hydrogen peroxide and hydroxyl radicals:  
A B
GSHGSSH  
Fig. 5 Chemical structure of glutathione  
 
The ability of the cell to regenerate GSH either by reduction of GSSG or by new synthesis of 
GSH is an important factor in the efficiency of that cell in managing oxidative stress. Under 
normal conditions, more than 95% of the GSH in a cell is reduced and so the intracellular 
environment is usually highly reducing (Carmody et al., 1999). In typical mammalian cells, 
the ratio of [GSH]/[GSSG] in the cytosol is 30:1, thereby maintaining very reduced redox 
potential (RP) of approximately 220 mV (Hwang et al., 1992). 
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Ascorbic acid 
Ascorbate (Vitamin C) can not be synthesised by mammals and therefore needs to be taken up 
through the diet. It is playing an essential role as an easily oxidized anti-oxidant and free 
radical scavenger. The oxidized form of ascorbic acid is known as dehydroascorbic acid. 
Reactive oxygen species oxidize ascorbate to dehydroascorbate. ROS are reduced to water 
while the oxidized forms of ascorbate are relatively stable and unreactive, and do not cause 
cellular damage. Ascorbic acid is also essential for the recovery of oxidized tocopherols. 
 
 
Fig. 6 Chemical structure of ascorbic acid. 
 
α-Tocopherol and Trolox C 
The term Vitamin E represents eight structurally related compounds, called also tocopherols 
and tocotrienols, each with their own subfamilies of α-(Fig.7 B), β-, δ- and γ-substances. They 
are also equipped for an antioxidant function, despite their lack of a thiol (-SH) group. In its 
function as a chain-breaking antioxidant, tocopherols rapidly transfers its phenolic H+ atom to 
a lipid peroxyl radical, converting it into a lipid hydroperoxide and a relatively stable radical 
form of the vitamin (Machlin and Bendich, 1987). The tocopheryl radical can be reduced to 
tocopherol by ascorbic acid or reduced glutathione or alternatively to be further oxidized to 
quinone (Bast et al., 2002).  
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Fig. 7 Chemical structure of α-tocopherol and Trolox C 
 
Trolox C (6-hydroxy-2,5,7,8-tetrametylchroman-2-carboxylic acid; Fig.7 B) is an α-
tocopherol derivative that is lacking the phytyl tail, which enables its water-solubility. On the 
other hand, the aromatic structure remains unchanged implying preserved antioxidant 
properties. 
 
Modulation of ion channels by ROS 
Oxidative stress has met continuously growing interest for its roles in the physiology and 
pathophysiology of immune defense, ischemia, and neurodegenerative disease, such as 
Parkinson's disease, Alzheimer's dementia, and multiple sclerosis. Reactive oxygen species 
modify membrane lipids as well as a variety of proteins, including membrane channels, 
affecting cellular functions in both detrimental and protective ways (Kourie, 1998). 
Ruppersberg demonstrated in 1991 that inactivation of A-type currents through Kv1.4 
channels is dependent on the cellular redox state in a cysteine-dependent manner 
(Ruppersberg et al., 1991). Oxidation decreases the conductance of Kv1.3, Kv1.4, Kv1.5, 
Kv3.4 (Duprat et al., 1995) and Kv3.3 channels (Vega-Saenz de Miera and Rudy, 1992), 
while it enhances K+-currents through human ether-a-gogo-related gene (HERG) K+-channels 
(Taglialatela et al., 1997). Modulation of K+-channel activity by cellular oxidative stress has 
emerged also as a significant determinant of vascular tone. Different kinds of ROS have been 
reported to modify various types of K+-channels in vascular tissues (Liu and Gutterman, 
 
 18
2002; Pomposiello et al., 1999; Sobey et al., 1997). Specific oxidative modulation of voltage 
activated K+-currents in cultured hippocampal neurons, as well as in slice CA1 pyramidal 
neurons by hydrogen peroxide and 1 pM AA has been demonstrated by the Müller lab 
(Bittner and Muller, 1999; Muller and Bittner, 2002, Angelova and Muller, 2006). 
 
Hippocampal Formation 
The entorhinal cortex (EC) is a part of the “limbic system” (MacLean, 1952). For a long time 
it was thought that the entorhinal cortex is primarily related to olfactory functions, however 
more recently it has been shown to also be involved in functions such as emotional and 
cognitive processes (Squire, 1992). The entorhinal cortex does receive major inputs from the 
olfactory bulb and cortex. Lately it has become clear from many studies, e.g. O'Keefe and 
Conway, 1978; Pouzet et al., 1999; Zola-Morgan and Squire, 1990, that the entorhinal cortex, 
together with the hippocampus, contributes importantly to learning and memory. 
The entorhinal cortex functions as a gateway to the hippocampal formation, because its output 
via the perforant pathway is the major cortical source of input to the hippocampus. 
Furthermore, together with the subiculum it also provides the major output of the 
hippocampus (Witter et al., 1989).  
The cells that give input to the hippocampus are predominantly present in layers II and III, 
most neurons in layer II are modified pyramidal cells, or stellate cells, whereas layer III 
predominantly consists of small pyramidal neurons (Fig. 8). In the rat, the layer II cells of the 
EC have been shown to project primarily to the dentate gyrus (Dolorfo and Amaral, 1998; 
Ruth et al., 1982; Ruth et al., 1988; Steward and Scoville, 1976). The entorhinal cortex layer 
III cells have been shown to project predominantly to CA1 and subiculum (Steward and 
Scoville, 1976).  
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Fig. 8 Schematic drawing of a section through rodent entorhinal cortex (modified after 
Lorente de Nó, 1934). 
 
Hippocampal formation damage in neurological diseases 
The entorhinal cortex is damaged in various brain diseases and in degenerating disorders, 
such as temporal lobe epilepsy (Du et al., 1993), schizophrenia (Arnold et al., 1995), 
frontotemporal dementia (Frisoni et al., 1999) and Alzheimer’s disease (Braak and Braak, 
1992; Braak and Braak, 1995; Braak and Braak, 1996; Gomez-Isla et al., 1996). In 
schizophrenia, there are controversial findings regarding the damage in the entorhinal cortex 
(Akil and Lewis, 1997; Krimer et al., 1997). 
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Changes in hippocampal formation in temporal lobe epilepsy 
Selective neuronal loss and active gliosis are the basic morphologic changes observed in 
temporal lobe epilepsy (Mathern et al., 1997). The entorhinal cortex is probably one of the 
primary sites in which temporal lobe seizures propagate and reverberate (Spencer and 
Spencer, 1994). In humans, early cell loss is most profound in the entorhinal cortex layer III 
(Du et al., 1993). In experimental studies of status epilepticus of rats, layer III of the medial 
portion of the entorhinal cortex is also suggested to be the most vulnerable (Du et al., 1995). 
At late stages, these changes are also prominent in CA1 region and in part of the subiculum. 
 
Changes in hippocampal formation in Alzheimer’s disease  
The entorhinal cortex is one of the cortical formations that are selectively vulnerable in 
Alzheimer’s disease. In AD, the damage in entorhinal cortex occurs very early in the disease 
course. Layer II shows neuronal loss and tangles formation in preclinical stages of AD and in 
patients with mild dementia (Braak and Braak, 1991). In later stages, amyloid accumulation 
and cell loss affect area CA1 and the subiculum.  
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AIM OF THE STUDY 
Modulation of a variety of voltage-dependent potassium channels by arachidonic acid has 
been well documented (Meves, 1994). Despite multiple hypotheses suggested and a lot of 
experimental work done, there is still uncertainty which of the hypothetic mechanisms of A-
type current accounts for modulation by fatty acids. Given the central importance of voltage-
gated potassium channels in neuronal excitability it is not surprising that probably several 
mechanisms contribute to their tight control. This study was designed to investigate whether 
oxidative processes also contribute to AA-induced modulation of IA. In order to test this 
hypothesis, some specific goals had to be defined: 
- What is the effect of AA in hippocampal neurons from acute brain slices? 
- Is this effect direct or an effect of one or more of its multiple metabolites? 
- How does AA affect neurons in different areas of the hippocampus? 
- Are there differences in A-type channels in untreated stellate cells and pyramidal 
neurons of the entorhinal cortex? 
- Do A-type currents respond differently to 1 pM AA in neurons of the CA1 and 
neurons of the entorhinal cortex? 
- Is oxidation involved in AA effects? 
- Is it possible to identify the molecular basis of these effects, and the involved 
subunits?  
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MATERIALS AND METHODS 
Brain slices  
Animals 
Experiments with brain slices were carried out on 14 to 21 days old male or female Wistar 
rats in compliance with international guiding principals for the use of animals in research. The 
number of animals was limited to the necessary number permitting reliable statistical analysis. 
According to the animal rights guidelines special procedures that minimize discomfort, pain 
and distress were applied. The animals were kept under standardized conditions and had 
access to water and dry food ad libitum. Light/darkness regime of 12:12 hours at a controlled 
temperature of 24 ± 1 ˚C was not inverted. 
Brain slice preparation 
Most of the experiments in this work were performed on horizontal hippocampus-entorhinal 
cortex slices (Fig.9). Prior to decapitation the animals were deeply anesthetized with ether. 
After decapitation the skin was cut with a scalpel from the caudal (posterior) to rostral 
(anterior) part, so that the calvarium could be uncovered. After careful opening of the skull 
with sharp scissors cutting along the still soft sutura sagitalis the two cranial pieces were 
peeled laterally. After careful removing of the Dura mater and disrupting the optic nerves the 
brain was rapidly (within half a minute) freed from the skull with spatula together with the 
Cerebellum and washed immediately with ice-cold ACSF, bubbled with 95% O2 and 5% CO2. 
Slicing was done at 4-8ºC in order to keep the tissue firm and to reduce metabolic activity. 
The preparation was done under submersion in ice-cold oxygenated ACSF. The Cerebellum 
as well as the frontal third of the brain was excised and both hemispheres were separated. The 
caudal third of each of the hemispheres was glued with the dorsal plane to the vibratome 
chamber using cyanoacrylate glue. Slice preparation was done from basal to dorsal direction. 
Brain pieces and slices were soaked in oxyenated ACSF (or high sucrose ACSF) during the 
whole process of cutting. The angle and vibration frequency of the blade were adjusted to 
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prevent the tissue being pushed while cutting the slices. Combined hippocampal-entorhinal 
cortex slices of 300 µm thickness were prepared using a vibrating microtome (Dosaka 
Microslicer DTK-1000, Kyoto, Japan). Slices were immediately and very carefully moved 
(using a brush) to an incubation chamber, containing oxygenated ACSF at room temperature 
(20-22˚C). There, the slices were allowed to recover for at least 1 hour before being 
transferred to the recording chamber. 
 
 
Fig. 9 Preparation of horizontal hippocampal slices (Witter et al., 2000). 
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Solutions 
As a nutrient solution for the brain slices during preparation as well as during the 
experimental phase artificial cerebro-spinal fluid (ACSF) was used (Table 1). This solution 
was continuously bubbled with carbogen gas (5% CO2, 95% O2) to maintain a pH of 7.4. 
While recording, ACSF was superfused at 3 ml/min at room temperature (~22oC). 
Table 1 Content of acute brain slice preparation and perfusion solutions. 
Compound ACSF (Ringer) /normal/ Sucrose cutting solution  
NaCl 129 mM 87 mM 
NaHPO4 1,25 mM 1,25 mM 
Glucose 10 mM 25 mM 
MgSO4 1,8 mM - 
CaCl2 1,6 mM 0,5 mM 
KCl 3 mM 2,5 mM 
MgCl2 - 7 mM 
Sucrose - 75 mM 
Stock I 
NaHCO3 26 mM 26 mM Stock II 
 
Both Stock I and Stock II were mixed with H2O daily in a ratio of 1:8:1 and bubbled with 
carbogen minimum 1 hour before use, to adjust the pH of 7.4. 
Although sucrose substitution for sodium or the use of 10 Mg2+: 1 Ca2+ instead of 1 Mg2+:1 
Ca2+ is reported to amend the viability of slices, the modified procedure that incorporates both 
of these ideas did not result in significant improvement of the slice quality. 
 
HEK 293 cells 
Heterologous expression of potassium channel cDNAs was done in human embryonic kidney 
cells, transformed with Adenovirus Type 5, American Type Culture Collection, 12301, 
Parklawn Drive, Rockville, Maryland 20852, USA; code designation HEK 293 or 293 cells. 
Maintaining HEK 293 cells in culture 
HEK 293 cells were grown in a monolayer in plastic petri dishes of 35 or 99mm. Under 
optimal growth conditions (37˚C, 5% CO2), 293 cells doubled about every 36 hours. To 
maintain consistency and successful transfection procedures low passage 293 cells were 
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employed. Untransfected HEK cells were grown on big culture plates (99 mm) in 10 ml 
complete growth medium (Table 2) and were split every 2 days (after reaching 80-90 % 
confluence). 24 hours before transfection 293 cells were harvested and replated onto small 
petri dishes (35 mm) in 2 ml complete medium at a density to reach around 30 % on the next 
day. The cultures were incubated for 24 hours at 37˚C in humidified cell-culture incubator 
(Heraeus, Hanau, Germany) in an atmosphere of 5% CO2. The medium was changed 1-2 
hours prior to transfection. 
Transient transfection of HEK-93 cell lines 
The standard calcium phosphate-mediated transfection of adherent cells (Graham and van der 
Eb, 1973) was used for transient transfection of HEK 293 cell lines with potassium channel 
cDNA. The cells were transfected with Kv1.4 and Kv4.2 potassium channel subunit cDNA.  
To prevent contamination sterile media, vials, instruments and cells in a vertical laminar flow 
hood were used. All solutions were sterilized by filtration trough 0.22 µm-pore filtre and were 
brought to room temperature before use. For each transfection plate two separate 0.5 ml 
polystyrene tubes were prepared:  
 
A   CaCl2/DNA co-precipitate                                    B   100µl 2x HBS (see Table 3)  
 
While vortexing the HBS solution, the CaCl2/DNA mixture were added dropwise to the tube, 
incubated for 30-40 min at room temperature, during which CaPO4-crystals precipitate with 
the adherent DNA. The solution was permitted to turn opaque, but no or only very few visible 
precipitates were allowed to form. After resuspending the CaPO4/DNA precipitate it was 
quickly and gently added dropwise onto the cells and rocked back and forth few times to 
evenly distribute the precipitate on the cells. By observing the cells under the microscope one 
could see very small black particles evenly distributed over the cells. The transfected 293 cells 
were incubated 4-5 hours at 5% CO2 and afterwards washed (3x) with sterile PBS (containing 
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no Ca2+ or Mg2+). Thereafter PBS was replaced with pre-warmed complete medium. 
Incubation of 48-60 hours was usually adequate for high expression rates of the protein of 
interest. 
The transfection efficiency drastically fell when HEK cells were of late passage or reached 
high confluence. Therefore it was of great importance to time the passage procedures well. 
Aliquots of early passages of the HEK cell line were stored in liquid nitrogen to ensure a 
renewable source of cells. To prepare HEK cells for freezing, cells with 80% confluence were 
washed once with PBS (containing no Ca2+ or Mg2+), trypsinized and harvested. Afterwards 
the cells were counted, collected by centrifugation (500 x g for 10 min.) and resuspended in 
4˚C Cell Freezing Medium at 1-2x106 cells/ml. 1ml aliquots were then dispended into labelled 
freezing vials and incubated at –20˚C for 1-2 hours, -80˚C overnight and subsequently 
transferred to liquid nitrogen (-196˚C). There the cells could be preserved for months to years. 
Nevertheless the viability of the frozen stocks must be confirmed two or more weeks later by 
starting a fresh culture. To defrost prepared aliquots, the vials were taken from liquid N2 and 
placed directly into a water bath (37˚C). After short time the cells were centrifuged and the 
pellet was resuspended in fresh warm MEM by trituration. 
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Culturing media 
Table 2 Content of HEK-293 cell line culturing media 
 Complete 
medium 
Freezing 
medium 
Washing 
medium 
Storage of 
compound/media supplied by 
MEM(-Glu) 88 % 10 % - 4˚C Gibco 
FCS 10 % 80 % - -20˚C Gibco 
L-Glu 1 % - - -20˚C Gibco 
P/S 1 % - - -20˚C Fa.Seromed/ Biochrom 
KG 
PBS - - 100 % 4˚C Gibco 
DMSO - 10 % - 18˚C /hood/ Merck 
 
MEM, minimum essential medium, FCS-fetal calf serum, L-Glu, L-glutamine; PBS-
phosphate buffer saline, DMSO, dimethyl sulfoxide. 
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Transfection buffers 
Table 3 Content of HEK-293 transfection solutions and buffers. 
 2xHBS /HEPES buffered 
saline/ CaCl2 A B 
NaCl 280 mM - - 
HEPES 50 mM - - 
NaHPO4 1,5 mM - - 
 
100µl 
2xHBS 
CaCl2 - 2 mM 12,3µl - 
cDNA /Kv1.4, Kv4.2 or 
EGFP/ 
- - 2-5µg - 
ddH2O/sterile/ - - to 
100µl 
- 
aliquots/storage 1 ml/ -20˚C 1 ml/ -
20˚C 
fresh fresh 
 
HBS, HEPES//buffered saline; ddH2O, double-distilled water; L-Glu, L-glutamine; 
NaHPO4, sodium hydrogen phosphate;  
 
In pyramidal neurons channels responsible for transient potassium currents are known to be 
comprised by two distinct principal (α) subunit genes: Kv1.4 and Kv4.2. In order to 
investigate probable differential modulation of Kv1.4 or Kv4.2 by AA or its derivatives and 
by radical oxygen species, Kv α-subunit cDNAs were separately transfected into HEK 293 
cells.  
One part of the recorded HEK 293-Kvα-expressing cells was co-transfected with EGFP-
cDNA as a reporter gene to identify transfected cells by fluorescence microscopy. However, 
this reduced transfection efficiency. 
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Superfusion solutions 
In HEK 293 cells patch-clamp experiments a saline with the following composition (in mM) 
was used as a perfusion solution: 
140 NaCl, 4 KCl, 2 MgCl2, 1 CaCl2, 10 HEPES, 5 glucose, pH 7.4. All solutions were 
always prewarmed to 37oC before use in experiments to exclude a temperature shock of the 
HEK-293 cells. 
Electrophysiological recordings 
Patch pipettes 
Patch pipettes were freshly pulled from borosilicate glass (GB 150F-8P, Science Products, 
Hofheim, Germany) using a horizontal micropipette puller (P-97 Flaming/Brown 
Micropipette Puller, Sutter Instrument, USA) and were then fire-polished (Microforge, 
Narishige, Japan). The tip of the pipette was filled with control intrapipette solution (IPS) (1-
2µl) and backfilled with IPS, containing the substance of interest. It is of great importance 
that no air bubbles or particles block the pipette tip. Patch pipettes had initial open-pipette 
resistances of 3-10 MΩ. Higher resistances lead to poorer electrical access to the cell, but also 
less washout of interior cell contents. 
Intrapipette solution (IPS) 
The recording solution had the following composition in mM: 120 KCl, 1 CaCl2, 10 HEPES, 
11 EGTA, 2 MgCl2, 20 Glucose; pH 7.3. The substances of interest were then dissolved in 
IPS (see Table 4). The filling solution was filtered with 0.22 µm filters (Nalgene 4-mm 
syringe filters with nylon membrane), filled into new 1 ml luer syringes and freshly–pulled 
plastic microtubes. For patch-clamp osmolarity and pH are critical, therefore they were 
adjusted for both perfusion (310 ± 10 mOsm/ kg, pH 7.4) and intrapipette (300 ± 10 mOsm/ 
kg, pH 7.3) solutions. All solutions were freshly prepared.  
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Pharmaka  
Most of the substances, used in this work, were prepared in stock solutions, if possible. Prior 
to experiment these compounds were diluted to required concentrations in perfusion or 
intrapipette solutions, depending on the application site and brought to the proper osmolarity 
and pH values. Unstable substances demanded preparation of fresh solutions. The following 
table gives an overview of the substances used, their concentrations and application sites. 
Table 4 Pharmaka  
 
Concentration 
Application 
site Function Notes 
Arachidonic acid 
/AA/ 1 pM intracellular 
cellular second 
messenger, precursor of 
eicosanoids 
Light- and oxygen 
sensitive 
Eicosatetraynoic 
acid /ETYA/ 100 pM intracellular 
non-metabolizable 
analogue of AA 
Light-, and oxygen 
sensitive 
Ascorbic acid 
/asc.acid/ 20 µM intracellular 
antioxidant 
Light-, temperature 
and oxygen 
sensitive 
 0.4 mM bath   
Glutathione /GSH/ 2-20 mM intracellular antioxidant  
 20 mM bath   
N-acetyl-cystein 
/NAC/ 20 mM 
incubation 
(extracellular) 
Antioxidant, 
precursor of GSH 
 
Trolox 
10 µM intracellular 
antioxidant, water 
soluble derivative of 
tocopherol 
 
 100 µM bath   
Hydrogen 
peroxide  /H2O2/ 
80 µM intracellular 
oxidizing agent 
 
Tetrodotoxin 
/TTX/ 1 µM bath 
fast sodium channel 
blocker 
† 
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AA and ETYA were stored as 1M stock solutions in DMSO at –20˚C. DMSO itself, diluted to 
pM concentrations had no effect on IA or IK(v). Ascorbic acid was used from freshly made 
stock, when needed and kept in dark container up to 5 days at –20˚C. GSH was stored as 20 
mM stock in IPS, when used for intracellular application. During experimentation intrapipette 
solutions were kept on ice in darkness.  
Voltage-clamp and discontinuous amplifier  
The main requirement of voltage-clamp procedure is to prevent changes in cell membrane 
potentials. That is why in voltage-clamp is generated compensation current, which is exactly 
as big as the current, which flows through the membrane, but in opposite direction. This is 
carried out by a negative feedback mechanism, by which the membrane potential is measured 
and compared with a reference value – the reference voltage. Every difference of the 
reference value from the actual measured membrane voltage activates a controller, which 
injects current with reversed direction to the cell. This compensation current is measured in 
patch-clamp experiments. It provides direct insight into membrane conductivity and the 
function of ion channels and ion transporters, by which it is determined. Simplifying, one 
could imagine the cell membrane as an Ohm resistor. In other words, the voltage is linearly 
dependent on the current (Ohm’s Law: U=R.I). Instead of the resistance R, one uses its 
reciprocal value, the conductance (1/R=g). The Ohm’s Law in this case is U=I/g or I= U*g. 
The voltage U is in this case the offset between reference voltage Uref and the reversal 
potential Urev for a given ion species, that carry the current: with I= (Uref- Urev).g.  
The current I is the most important measurement category for all voltage-clamp amplifiers 
and every current change is directly proportional to the changes of the membrane 
conductivity. 
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Recording electrode 
Chlorided silver wire, connected with the probe end of the amplifier is inserted into the glass 
patch-pipette filled with IPS and serves as a recording electrode. 
Experimental setup  
In the recording chamber brain slices were superfused with carbogenated ACSF with a flow 
rate of 3 ml/min or HEK cells media was replaced with pre-warmed HEK perfusing saline. 
The electrophysiological experiments were performed at room temperature (~20°C). ECLII 
stellate cells and ECLIII and CA1 pyramidal neurons from acute brain slices, as well as 
transfected HEK 293 cells were visualized and identified under an upright microscope 
(Olympus BX 51WI, Germany), equipped with IR-DIC optics. In the entorhinal cortex, L III 
pyramidal neurons were classified by their triangular somata exhibiting one principal apical 
and two to three minor basal dendrites. L II stellate neurons were identified by their irregular 
polygonal somata. They were larger than pyramidal neurons and gave rise to four or five 
roughly equivalent dendrites, forming a stellate morphology. CA1 pyramidal neurons were 
easy to distinguish, because they are organized in clear-cut subfield within the hippocampus.  
HEK cells grew in monolayer, but 2-4 days after plating there was a tendency of forming 
confluent cumuli. In this case the measurements were performed on the remaining single 
cells.  
For electrophysiological recordings, only healthy cells were selected. These are cells with 
defined round borders, bright, with a really good contrast and a smooth appearance. Cells with 
rough, spotty surface or dark colour, even if they had good contrast were discarded, because 
those are usually seriously damaged, about to become apoptotic and do not allow formation of 
seals. In some cases swollen cells allowed seal formation, but no longer whole-cell 
recordings.  
 
 33 
When the pipette is brought across the air-saline interface, positive pressure (0.1-0.5 psi) was 
applied to prevent tip contamination and to clean cell surface from tissue debris (in slices). As 
the HEK cells grow in monolayer high pressure would be destructive for them. After forming 
a bleb on the cell surface, tight seal (> 1 GΩ) was achieved by application of low negative 
pressure, using a 1 ml-syringe. Whole-cell break-in was accomplished by giving a very brief, 
sharp pulse of suction, considerably smaller in the case of HEK 293 cells. Access resistance 
(Ra) ranged from 10–14 MΩ, and was compensated by up to 60%; data were discarded if Ra > 
15 MΩ. Input resistance was measured at a holding membrane potential level close to resting 
membrane potential (RMP) from the voltage response elicited by a small current pulse (-60 
pA). Only cells that showed stable RMP negative to -60 mV and Ri > 120 MΩ (in current-
clamp mode) were selected for study. Pharmacological tests of so selected cells were 
completed within 15 min. and corrected offline for eventual run down effects. Membrane 
potential of the cells was held at – 80 mV. All experiments were conducted at room 
temperature (20 - 22 ºC). 
Experimental protocols 
In whole-cell patch-clamp mode, total outward potassium currents were activated after 800ms 
hyperpolarizing prepulse at –110 mV (to remove inactivation) by subsequent depolarization 
of the membrane to potentials between –80 and +50 mV in increments of 10 mV (Fig.10 A1). 
When followed by 50 ms interval at –20 mV IA inactivated completely (Fig.10 A2) permitting 
later isolation of IA from the mixed currents.  
A1 B1
A2 B2
 
Fig. 10 Test potential protocols for activation and inactivation of total outward and 
delayed rectifier potassium currents. 
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Delayed rectifier potassium currents were also elicited from different potentials (-110 to 
+20mV, 10 mV increments) and recorded at +30 mV (Fig.10 B). Ik(v) were non-inactivating in 
the investigated range of  durations of voltage pulses. Whole-cell patch-clamp recordings 
were maintained in voltage-clamp mode, using an EPC-9 amplifier with built-in ITC-16 
interface board, controlled by Pulse/PulseFit software (both HEKA Electronik, Lambrecht, 
Germany). The current signals were filtered at 3 kHz and 10 kHz and stored on a disk. The 
P/n method incorporated in Pulse/PulseFit software was used for leak correction (leak holding 
at –80 mV). 
Data and statistical analysis 
By depolarization of the membrane potassium permeability through a voltage-gated channel 
rises rapidly and then decays slower than it activates. These two processes could be described 
with the terms activation and inactivation. When the channels open, a mechanism is put into 
action to close the channel again. The special closed state in this situation is referred to as the 
inactivated state. The channels indeed possess two different types of gates. Closing of the 
inactivation gate is time dependent, whereas opening it is voltage dependent. The inactivation 
state can be considered time independent and is therefore termed steady-state inactivation.  
On single channel level activation and inactivation corresponds to a change in probability of 
given channel to open or close upon depolarization. Inactivated channels could not be 
activated to conducting state until their inactivation is removed. Whole-cell recording makes 
possible to follow the changes in this probability and the duration of these states in multiple 
channels on the same time. The voltage-dependence of open state probability could be 
measured as followed: by a negative holding potential all channels of interest are brought to a 
state, from which activation is possible (closed state). Then the membrane potential is 
manipulated to more positive values (depolarization) and one part from the channels is 
opening. The recorded amplitude of the ionic current is a measure of the probability of the 
channels to open at certain test potential at the same time. The experiment is then repeated for 
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different test potentials and voltage-conductance relation curve is built. The conductance at 
each potential is normalized to the maximal conductance for the cell and plotted vs. test 
potentials. The resulting curve is sigmoidal and can be fitted with Boltzmann function (see 
below). Different pulse protocols and similar procedure of calculation is applied to describe 
steady-state inactivation of the channels. Both curves describe the voltage dependence of 
closed and opened states of the channels. These curves could be influenced by pharmaka, etc. 
If there is an overlap between the activation curve and the inactivation curve, then there will 
be a small, constant current in the area of overlap, called window current, that contribute to 
the setting of the resting membrane potential. A characteristic value that could be derived 
from voltage-conductance relation is the voltage (V50), at which exactly the half of the 
channels are activated (open or closed). Another essential parameter that describes the 
dependence of the channel conductivity from membrane potential changes is the slope of the 
resulting curve k. Other important parameters that could be derived at each test potential are 
the time constants of activation and inactivation and the maximal amplitude of the current at 
each voltage steps. 
Separation of fast and persistent K+-currents using prepulse inactivation 
Prepulse inactivation takes advantage of the differences in the inactivation properties of the 
fast (transient) and sustained (delayed rectifier) K+ currents (Klee et al., 1995). TTX at 1 µM 
was included in the bath solution to isolate transient and persistent potassium currents from 
fast TTX-sensitive Na+ currents (which are completely blocked by this TTX concentration). 
K+ currents were evoked from a holding potential of -110 mV to test pulses ranging from -80 
to +50 mV in 10 mV steps. Transient K+-current (Fig.11, B) was obtained by subtracting the 
current obtained after a -20 mV prepulse, which elicits only the delayed rectifier K+ current 
(Fig.11, C), from the current obtained after more hyperpolarized prepulse (-110 mV), which 
elicits both fast and persistent K+ currents (total outward potassium current, Fig.11, A). 
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A
B C
 
Fig. 11 Procedure for potassium current separation 
 
The current traces were analysed “offline” using combination of Pulse/PulseFit, IgorPro and 
Prism software.  
 
Data analysis 
Current subtraction, rescaling and curve fitting were performed with IgorPro (WaveMetrics 
Inc.). Currents at each test potential were converted to conductances, using:  
 g =I/(Vi-Ek), where I is the peak outward current, EK is the reversal potential, and V i is the 
test pulse voltage. 
Voltage-conductance relations for activation and steady-state inactivation were plotted and 
fitted with the Boltzmann single exponential equations for  
activation                                  g/gmax = 1/(1 + exp(- (V - V0.5)/k)) (1)  
and inactivation                        g/gmax = 1/(1 + exp((V - V0.5)/k)) (2),  
where V0.5 is the voltage for half-maximal activation in millivolts, V is the test pulse voltage, k 
is the corresponding slope factor, and g/gmax - the normalized conductance.  
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For effects on the maximum amplitude, currents at each recording time, measured at +30 mV, 
were normalized to the current at time=0 (immediately after obtaining whole-cell 
configuration, ‘control’) and plotted against time. Data are presented as means ± SEM 
(Standard Error of Means) or % of control. Statistical analyses of the data were performed 
with Prism (GraphPad Software Inc.) using Student’s unpaired t-test. Probability of p<0.05 is 
considered to be significant.  
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RESULTS 
Oxidative modulation of transient and delayed rectifier potassium 
currents in CA1 pyramidal neurons 
In whole-cell voltage-clamp experiments of CA1 pyramidal neurons, total outward potassium 
currents were evoked after a 800 ms hyperpolarizing prepulse to –110 mV (to remove 
inactivation) during subsequent step depolarization of the membrane to potentials between –
80 and +50 mV (increments of 10 mV, 200 ms duration). When the prepulse was followed by 
an additional 50 ms step at –20 mV, IA inactivated completely and isolated delayed rectifier 
currents (IK(V)) were recorded during subsequent voltage steps (Fig.12 A,B, pulse protocols 
see inset Fig.12). By subtracting delayed rectifier from mixed currents (IK(V))+IA), IA was 
isolated, as shown in Fig. 12 C.  
Potassium currents in untreated CA1 pyramidal neurons 
In control conditions, the evoked transient potassium current IA had a maximum amplitude of 
0.5-4 nA at +30 mV that was reached within 4 ms after the beginning of the voltage pulse. IA 
inactivated completely with a time constant of 7.8 ± 1.5 ms (Fig. 12 C, Table 5). The 
maximal amplitude of IA was stable over 15 min of whole-cell recording (-10.9 ± 4.6 %, 
Fig.12 C, Table 5). 
 
 39 
2 nA
50 ms
900 s
0 s
20 ms
360 s
900 s
2 nA
0 s
C
D
0s, control
B 900s, control
IK(V) + IA IK(V)
100 ms
A
IK(V) + IA IK(V)
5 nA
 
Fig. 12 Native IA and IK(V) in control condition in CA1 pyramidal neurons. 
A,B Original traces showing total outward potassium(IK(V) + IA) and delayed rectifier (IK(V))currents at 
0 s (A) and 900 s (B) after reaching whole-cell configuration. C Subtracted transient potassium current 
(IA) recorded at +30 mV over time. D Delayed rectifier current at +30 mV over time. 
Like IA, IK(V) was stable under control conditions with a slight decrease of the current 
amplitude over 15 min (-12.8 ± 2.3 %, Fig.12 D, Table 6). That minimal reduction of both 
currents in control condition most probably could be due to a ‘run-down’ of these currents, 
suggesting that important cytoplasmic factor(s) are subject to wash-out.  
 
Modulation of transient IA and delayed rectifier currents IK(V) by 
arachidonic acid 
When 1 pM arachidonic acid (AA) was included in the patch pipette, IA decreased over time, 
starting within 6 min after obtaining the whole-cell configuration. After 15 min of 
intracellular AA application through the patch pipette IA was reduced by -41.8 ± 5.5 % (n=9; 
p<0.01, Fig.13 B, C). Inclusion of AA in the patch pipette did not affect the inactivation time 
constant of IA (Fig.13 D, Table 5). 
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[AA]i = 1pM
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100 pM [ETYA]i 
IA % 
E 900s, AA 
IK(V)+IA IK(V) 
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D 0s, AA 
IK(V)+IA IK(V) 
3 nA
1 pM [AA]i 
 
Fig. 13 Suppression of IA by arachidonic acid (AA) in CA1 pyramidal neurons. 
A: control; B, C: Intracellular application of 1 pM AA reduces the maximal transient potassium 
current (IA) over time. The non-metabolizable AA analogue ETYA shows similar effect on IA at 100-
fold higher concentration (C). D, E: Raw current traces for combined IA and Ik(v) and for delayed 
rectifier currents (pulse protocols: inset in E).Currents are shown for control immediately after 
obtaining whole cell configuration (D, 0 s AA), after and after 900 s of recording with 1 pM of AA in 
the patch pipette (E). 
 
In order to test whether the effects of applied AA on IA were due to AA itself or one of its 
many bioactive metabolites, the non-metabolizable AA analogue eicosatetraynoic acid 
(ETYA) was employed. ETYA is neither hydrolyzed by cyclooxygenase, lipoxygenase, nor 
by cytochrome P450, but furthermore blocks the activities of these enzymes. Intracellular 1 
pM ETYA was ineffective in reducing IA. Intracellular application of a 100-fold higher 
concentration of ETYA (100 pM) reduced IA to a similar extent as 1 pM AA (-47.1 ± 8.7 %, 
n=7, Fig.13 C). Like AA, ETYA did not affect maximum amplitude of Ik(v) (not shown). 
Fig.14 shows that IK(V) did not change its maximal amplitude in the presence of 1 pM 
intracellular arachidonic acid (-15.2 ± 1.8 %, n=9) in comparison to control (-12.8 ± 2.3 %, 
n=9). 
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control    0s control  900 sD1 D2 
20ms  
Fig. 14 The delayed rectifier current Ik(v) is not affected by AA in CA1 pyramidal 
neurons.  
A, B: Maximal Ik(v) recorded at 0 s and at 900 s of whole cell recording shows a 13% decrease over 
time in control (A) as well as with 1 pM AA in the patch pipette (B). C: Plot of Ik(v) amplitude over 
time of whole cell recording for control and for AA. D, E: Original current recordings of Ik(v) for 
several voltage steps (see inset in C) for control (D) and for AA at 0 s (D1, E1) and 900 s (D2, E2) of 
whole cell recording. 
 
 
The conductance–voltage plot of Fig.15 A, left curves, illustrates that AA shifted steady-state 
of inactivation to the left by 11 mV in CA1 pyramidal neurons in rat brain slice, in addition to 
the reduction of maximal conductance described above. AA did not affect the voltage 
dependence of activation of the transient potassium current (Fig.15 A, curves on the right 
side). 
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Fig.15 Intracellular AA (1pM) shifts steady-state inactivation, but not voltage 
dependence of activation of IA in CA1 pyramidal neurons. 
A: Conductance-voltage relations and Boltzmann fits for inactivation (left curves) and activation (right 
curves) of IA. Inset: Pulse protocols for determining voltage dependence of steady state inactivation 
(left) and of activation (right). Red part shows length of the traces below. B and C: Representative 
recordings for inactivation (B) and activation (C).D: voltage-conductance dependence of IK(V) and 
pulse protocols for activation of IK(V) (inset). E: Original recordings of IK(V) activation in control 
conditions and in the presence of 1 pM AA. 
 
Oxidative mechanism in reduction of the transient potassium current IA by 
arachidonic acid 
AA and ETYA may affect protein function by binding-induced conformational changes. 
Alternatively, both molecules are free radicals that can oxidize certain amino acids. To test 
for an involvement of oxidative effects of AA was used together with antioxidants, 
glutathione (GSH), ascorbic acid and Trolox (water-soluble analogue of α-Tocopherol) either 
alone or in different combinations. 
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Influence of glutathione on arachidonic acid-mediated effects  
Figure 16 B illustrates the surprising finding that when GSH (20mM) was included in the 
patch pipette, the AA effect on the maximal IA was not inhibited, but actually enhanced (-61.6 
± 5.8 % at 15min). In addition, reduction of IA was accelerated, as visible by significant 
reduction of IA after only 3 min of whole-cell recording (*, -44.1 ± 9.3 %, n=6 for AA + 
GSHin; as compared to -2.4 ± 4.8 %, n=9 for AA alone, Fig. 16 B) and inactivation was 
significantly slowed (p<0.01, Fig. 16 C inset). GSH itself had neither effect on IA nor on IK(V) 
maximal conductance(n=6, Tables 5 and 6; Fig.20 A, D). The augmentation of the AA effect 
by GSH suggests that redox reactions may be responsible for reduction of IA by AA and by 
GSH. 
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Fig. 16 Interaction of AA and antioxidants with IA. in CA1 pyramidal neurons  
A, B: GSHi enhances the AA effect on IA (A1, B: blue line), particularly early after begin of 
recording/application (*), while ascorbic acid blocks the AA effect (A2, B: green line). C, D: GSHi 
and ascorbic acido do not prevent the AA-mediated shift in steady-state inactivation (C, D, control=0 s 
vs. 900 s, left curves) but ascorbic acid slightly reduces it and shifts as well the activation curve to 
more negative potential (D, right curves). AA+GSHi (but not AA, only) slow inactivation of IA, as 
demonstrated by an overlay of traces after scaling to the same amplitude (C, inset, trace=40 ms). 
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Influence of glutathione and ascorbate on arachidonic acid–mediated effects 
In contrast to GSH, ascorbic acid (0.4 mM), an antioxidant that apparently crosses cell 
membranes easily, blocked reduction of IA when applied by the bath in addition to AA + 
GSHin (Fig. 16 A2, B-green line). In slices superfused with ascorbic acid only, IA decreased 
during whole cell recording over 15 min steadily to 40.9 ± 6.7 % and IK(V) to 60.3 ± 7.3 % of 
initial current amplitude (n=5). Under this conditions, tau of IA inactivation was also 
significantly slowed (p<0.01, Table 5), further supporting that ascorbic acid can catalyze 
oxidative reactions with these channels, depending on the oxidative stress in the vicinity of 
the membrane. 
Moreover, combination of GSHin and ascorbic acid did not prevent the AA-mediated shift in 
steady-state inactivation (Fig. 16 D), further suggesting that this shift is caused by a 
mechanism independent of reduction of maximal conductance. GSHin plus AA had, like AA 
alone, no effect on voltage dependence of activation. Combination of GSH and ascorbic acid 
plus AA caused a 6 mV shift of activation to more negative potentials that is statistically 
significant with 95 % confidence (Fig. 16 D, right curves). 
Influence of Trolox on arachidonic acid-mediated effects  
Despite its water solubility Trolox, like tocopherol, is assumed to primarily protect membrane 
lipids and transmembrane protein segments from oxidation. In slices superfused with Trolox 
(100 µM), both IA and IK(V) were completely stable during 15 min whole cell recording.  
The inactivation time constant of IA was progressively slowed over 15 min during whole cell 
recording from 4.5 ms to 9.9 ms (p<0.01, Table 5). Figure 17 A shows that intracellular 
application of AA together with Trolox, that is applied from both sides of the cell membrane, 
did also enhance the early effect of AA on IA (Fig. 17 B, *). With prolonged recording time in 
the presence of Troloxin/out IA showed significant recovery (Fig. 17 B). Again, voltage 
dependent inactivation showed responses independent from modulation of maximal 
conductance. Troloxin inhibited the AA shift of steady-state inactivation (Fig. 17 C). 
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Fig. 17 Interaction of AA and antioxidants with IA in CA1 pyramidal neurons. 
A, B: Intracellular application of the vitamin E analogue Trolox (10 µM) with AA does not prevent 
reduction of IA (A1, B: blue line), but Trolox, applied from both sides of the cell membrane, does 
significantly recover IA with prolonged recording time (A2, B: green line). Intracellular application of 
10 µM Trolox by itself reduces IA similar to 1 pM AA (B: black line). C: Troloxi inhibits the AA shift 
of steady-state inactivation (left curves). There is no shift in voltage dependence of activation (right 
curves, control=0 s vs. 900 s). D: In the presence of Trolox on both sides of the membrane plus AAi, 
steady state inactivation shifts over 900 s recording time by -12mV to more negative potential, similar 
to the effect of AAi or of Troloxi. 
 
 
The voltage dependence of activation of IA was unchanged. Surprisingly, AAi in the presence 
of Trolox on both sides of the membrane shifted steady state inactivation by -12 mV to more 
negative potentials (over 15 min), similar to the effect of AAi or of Troloxin alone. For the 
triple combination (AAi + Troloxin,out) there was no shift of voltage dependence of activation 
of the transient potassium current (Fig. 17 D, curves on right side). 
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Effects of H2O2 on outward potassium currents 
To evaluate direct effects of oxidative modulation of IA (in the absence of AA), the non-lipid 
oxidizing compound hydrogen peroxide (H2O2) was applied via the patch pipette. Generally, 
80 µM H2O2 mimicked the effect of 1 pM AA on the maximal amplitude of IA (-79.6 ± 1.9 %, 
p<0.01, n=6, Fig. 18A). Like AA, it also shifted the voltage dependence of inactivation to 
more negative potentials (-7mV, Fig. 18 B, left curves). Unlike AA, H2O2 in addition shifted 
the voltage dependence of activation to more negative potentials (-6 mV, Fig. 18 B, right 
curves) and slowed inactivation of IA (p<0.05, Table 5). The effects of H2O2 further support 
the idea that modulation of IA by AA is mediated primarily by oxidative reactions. Therefore 
it was tested for effects of antioxidants on the effects of H2O2, expecting complex changes as 
described above for AA. 
Influence of glutathione on H2O2–mediated effects on potassium currents 
The physiological antioxidant GSHin (20 mM) strongly reduced inhibition of maximal IA by 
H2O2 (-34.8 ± 7.2 %, n=4, Fig.18 A) and eliminated the H2O2 mediated shift of steady state 
inactivation (Fig. 18 C). While H2O2 shifted the voltage dependence of activation to the left, 
H2O2 in the presence of GSHin caused a shift to the right (+7 mV, Fig. 18 C). In addition, the 
slope of the conductance voltage relationship was decreased (k=14.9 ± 0.8 for H2O2 and 
k=11.6 ± 0.7 for H2O2 plus GSH) and slowing of IA inactivation was enhanced (p<0.001, 
Table 5). 
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Fig. 18 Effects of intracellular H2O2 (80 µM) and antioxidants on IA in CA1 pyramidal 
neurons.  
A: H2O2 mimics the effect of AA on maximal IA (red line). This effect is not enhanced but inhibited by 
GSHi or GSHi+ascorbic acido (green and blue line, respectively). B: H2O2 shifts voltage conductance 
relations of inactivation (left curves) and activation (right curves) to more negative potentials. C: 
GSHi eliminates the H2O2 mediated shift in inactivation (left curves), but for activation causes a shift 
to more positive potential and change in slope (right curve). D: In the presence of ascorbic acido, GSHi 
+ H2O2 shift inactivation and activation of IA by -22 mV to more negative potentials. E: 
Representative current traces of IA for determination of the voltage dependence of activation for 
control immediately after obtaining whole cell configuration (E1) and after 900 s of recording with 
H2O2 in the patch pipette (E2). 
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Influence of glutathione and ascorbate on H2O2–mediated effects on potassium 
currents 
Addition of ascorbic acid to the ACSF (0.4 mM), appeared to strengthen inhibition of the 
H2O2 effect by GSHin on maximal IA amplitude (-31.5 ± 4.9 %, n=4, Fig. 18 A). In contrast, 
ascorbic acid did not support GSHin inhibition of the shifts of voltage dependence of 
inactivation and of activation, but even enhanced shifts caused by H2O2 by more than 150% 
(Fig. 18 D, Table 5). Unlike with H2O2+GSHin there was no significant change of slopes, 
neither of voltage dependence of activation, nor of inactivation (Fig. 18 D, Table 5). IA 
inactivated much faster in the presence of ascorbic acid, but tau still almost doubled from 5.7 
to 9.8 ms during 15 min whole cell recording with H2O2 + GSHin (p<0.01, Table 5). 
 
In agreement with results reported for neurons in primary cultures, H2O2 also suppressed the 
delayed rectifier potassium current IK(V) in CA1 pyramidal neurons in brain slices (-63.2 ± 5.1 
%, n=6, Fig.19 A, C, Table 6). H2O2 shifted the voltage dependence of activation to more 
negative potentials (from 1.4 ± 1.5 mV to -5.7 ± 1.5 mV, n=7, Fig.19 B). GSHin and also 
GSHin plus ascorbic acid inhibited reduction of I k(v) by H2O2, (-21.0 ± 5.3 %, n= 4 and –23.0 
± 3.9 %, n=4, respectively, Fig.19 A). 
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Fig. 19 Effects of intracellular H2O2 (80 µM) and antioxidants on IK(V) in CA1 pyramidal 
neurons.  
A: H2O2 suppresses the delayed rectifier potassium current IK(V), and this effect is inhibited by GSHi or 
GSHi+ascorbic acido (+GSHi and +GSHi,asc.acido, respectively). B: H2O2 shifts voltage dependence of 
activation of IK(V) to a more negative potential. C, D: Representative traces of IK(V) for determination of 
voltage dependence of activation for control immediately after obtaining whole cell configuration (C1, 
D1, 0 s) and after 900 s recording with H2O2 (C2) or H2O2 + GSHi in the patch pipette (D2). 
Recordings of D have been obtained in the presence of ascorbic acido. 
 
 
Control antioxidant studies 
Due to unexpected behavior of antioxidants in this set of experiments with arachidonic acid, 
control (only in the presence of antioxidants) studies on IA and IK(V), were performed in CA1 
neurons in order to investigate potential K+-current susceptibility to antioxidant exposure. 
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Intracellular GSH 
Application of 20 µM GSH to the intrapipette solution for 15 min resulted in a significant 
leftward shift of steady-state inactivation of IA compared to that observed in controls (-54.6 ± 
0.3 mV and -65.1 ± 0.5 mV, respectively). Glutathione by itself reduced the rate of 
inactivation of IA within 15 min. (τ=8.5 ± 1.3 vs. τ=12.3 ± 2.0). Under GSHin conditions, the 
maximal conductances of IA and IK(V) were reduced to ~20 % (Fig.20 A, D). 
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Fig. 20 Effects of GSH and ascorbate on K+ currents behavior in CA1 pyramidal 
neurons.  
A, D: Effects on the maximal amplitude of IA (A) and IK(V) (D). B, C: Steady-state inactivation and 
activation curves for control (black line) and GSH (blue) and ascorbic acid (green) conditions. E, F: 
Kinetics of activation of IK(V) in the presence of GSH (E) and ascorbate (F). 
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Extracellular ascorbic acid  
The perfusion of the slices with 0.4 mM ascorbate reduced significantly the maximal 
amplitude of IA to -59.1 ± 6.7% as well as the maximal amplitude of IK(V) to -39.7 ± 7.3% 
(Fig.20, A and D). Ascorbic acid applied on the outer side of the membrane did not affect the 
kinetics of activation and steady-state inactivation of IA. 0.4 mM ascorbate, applied trough the 
perfusion, did not influence the activation of IK(V) as well (Fig.20 E, F).  
Intracellular Trolox  
Inclusion of 10 µM Trolox to the patch pipette led to significant decrease of the peak current 
amplitude of IA to -61.1 ± 2.7 % and those of IK(V) to -39.4 ± 10.8 % (Fig.21 A, D-blue line). 
Intracellular Trolox shifted voltage dependence of activation (from -21.3 ± 1.2 mV to -13.4 ± 
1.0 mV) and inactivation (from -44.8± 0.4mV to -54.0 ± 0.1 mV) of IA Troloxin increased the 
IA time constant of inactivation (τ = 4.5 ± 0.6 at 0s and τ = 9.9 ± 1.4 at 900 s).  
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Fig. 21 Effects of Trolox on K+ currents behavior in CA1 pyramidal neurons.  
A, D: Effects on the peak amplitude of IA (A) and IK(V) (D). B, C: Steady-state inactivation and 
activation curves of IA in control (black line) and after intracellular (blue) and extracellular (green) 
application of Trolox. E, F: Activation kinetics of IK(V) in the presence of Trolox in(E) and Trolox out 
(F). 
 
 52
On Fig.21 E, IK(V) voltage-conductance relation of activation in the presence of Trolox in the 
patch pipette showed a small shift (from 0.5 ± 0.9 mV to -4.5 ± 0.7 mV, n=5) to more 
hyperpolarizing values. 
 
Extracellular Trolox  
Bath application of 100 µM Trolox did not influence IA or IK(V) in any way. There were 
neither changes in maximal amplitude nor in the kinetic of activation and steady-state 
inactivation of these currents (Fig.21 A, C, D, F-green line, Table 5). Trolox out did not affect 
the rate of inactivation of IA as well. 
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Table 5 Overview of effects of oxidants and antioxidants on behavior parameters of IA in CA1 pyramidal neurons. 
 
 
I A   CA1  
n 
 
 
max 
amplitude, 
% of 
control 
V 50a 
0 min  
mV 
V 50a 
15 min  
mV 
kactivation
0 min 
ka 
15 min 
V 50i  
0 min 
mV 
V 50i  
15 min 
mV 
kinactivation 
0 min 
ki 
15 min 
τi 
0 min  
ms       
τi  
15 min   
ms       
control 9 -10.9 ± 4.6  
-14.3±0.3 
 
-18.1±0.5 
 
7.9 ± 0.3
 
7.8 ±0.4 
 
-38.1±0.7 
 
-36.7±0.6 
 
9.2 ± 0.5 
 
9.3 ± 0.5 
 
7.8 ± 1.5 
 
8.5 ± 1.4 
 
+ 1pM AA 9 -41.8 ± 5.5  
-18.1±0.4 
 
-19.2±0.9 
 
7.8 ± 0.4
 
8.1 ±0.8 
 
-41.4±0.4 
 
-53.6±0.6 
 
10.2 ± 0.3 
 
11.3±0.6 
 
8.1 ± 1.3 
 
10.4±1.7 
 
control 
GSHin 
8 -15.5±7.2  
-20.1±0.7 
 
-25.0±1.2 
 
11.5±0.7 
 
13.5±1.1
 
-54.6±0.3 
 
-65.1±0.5 
 
6.4 ± 0.3 
 
5.9 ± 0.4 
 
8.5 ± 1.3 
 
12.3±2.0 
 
AA+GSHin 6 -61.6 ± 5.8  
-29.2±0.9 
 
-21.5±1.0 
 
13.0±0.9 
 
12.3±0.9
 
-43.0±0.8 
 
-58.7±0.7 
 
10.1± 0.7 
 
12.3±0.6 
 
11.9±2.5 
 
21.3±3.6 
 
control 
asc.acidout 
5 -59.1± 6.7  
-22.4±0.9 
 
-26.6±1.6 
 
12.9±0.8
 
16.3±1.5
 
-49.5±0.3 
 
-56.5±0.8 
 
9.8 ± 0.3 
 
9.5 ± 0.7 
 
9.9 ± 1.0 
 
15.8±2.3 
 
AA+GSHin/ 
asc.acidout 
4 -23.6 ± 11.8  
-10.9±0.8 
 
-18.9±0.9 
 
13.2±0.7 
 
13.8±0.8
 
-44.7±0.6 
 
-56.0±0.9 
 
10.5 ± 0.5 
 
10.7±0.8 
 
12.9±4.9 
 
18.3±5.1 
 
control 
Troloxin 
5 -61.1±2.7  
-21.3±1.2 
 
-13.4±1.0 
 
13.5±1.0 
 
14.2±0.9
 
-44.8±0.4 
 
-54.0±0.1 
 
9.9 ± 0.4 
 
9.0 ± 0.7 
 
4.5 ± 0.6 
 
9.9 ± 1.4 
 
AA+Troloxin 7 -47.6 ± 12.2  
-19.5±0.8 
 
-18.2±1.0 
 
11.7±0.7 
 
13.1±0.9
 
-50.2±0.5 
 
-50.3±0.7 
 
11.3 ± 0.5 
 
11.8±0.7 
 
8.4 ± 3.1 
 
13.3±3.7 
 
control 
Troloxout 
4 -6.6 ± 9.1  
-28.1±1.4 
 
-32.5±1.3 
 
11.3±1.3 
 
12.8±1.2
 
-68.3±0.8 
 
-68.4±0.8 
 
6.7 ± 0.7 
 
8.5 ± 0.7 
 
6.1 ± 0.8 
 
7.5 ± 1.2 
 
AA+Troloxin, 
out 
4 -26.8 ± 1.1  
-20.3±2.1 
 
-25.5±1.0 
 
14.1±1.8 
 
13.2±0.8
 
-45.6±0.6 
 
-58.0±0.7 
 
9.5 ± 0.5 
 
12.0±0.6 
 
8.9 ± 0.9 
 
10.7±1.1 
 
+80µM H2O2 7 -79.7 ± 1.9  
-12.9±0.8 
 
-20.8±0.9 
 
12.2±0.7 
 
14.9±0.8
 
-55.0±0.6 
 
-63.6±0.5 
 
8.7 ± 0.5 
 
9.0 ± 0.5 
 
7.9 ± 1.6 
 
13.5±1.5 
 
H2O2 +GSHin 4 -34.8 ± 7.2  
-26.1±1.2 
 
-17.2±2.0 
 
11.5±1.1 
 
16.6±1.6
 
-47.4±0.4 
 
-50.2±0.8 
 
10.6 ± 0.4 
 
11.6±0.7 
 
10.0±3.3 
 
19.5±2.6 
 
H2O2 
+GSHin/ 
asc.acidout 
4 -31.5 ± 4.9  
-11.8±0.4 
 
-34.3±1.4 
 
10.5±0.3 
 
12.8±1.2
 
-44.9±0.5 
 
-67.8±0.6 
 
9.1 ± 0.4 
 
8.4 ± 0.5 
 
5.7 ± 1.0 
 
9.8 ± 1.0 
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Table 6 Overview of effects of oxidants and antioxidants on behavior parameters 
of IK(V).in CA1 pyramidal neurons. 
 
 
I k(v)   CA1  
n 
max amplitude  
% of control 
V50activation  
0 min 
V50a  
15 min 
kactivation  
0 min 
ka  
15 min 
control (2-6.8 nA) 
9 -12.8±2.3 %  
6.3±1.1 
 
0.1±1.0 
 
18.5±1.0 
 
18.8±0.9 
 
+ 1pM AA 9 -15.2±1.8%  
5.3±0.9 
 
-2.8±1.0 
 
17.3±0.8 
 
18.6±0.9 
 
control GSHin 8 -20.8±5.7  
3.8±0.8 
 
1.2±0.7 
 
16.4±0.7 
 
16.2±0.6 
 
AA+GSHin 6 -13.5±4.6%  
0.7±1.3 
 
-1.9±0.9 
 
19.1±1.1 
 
17.3±0.8 
 
control asc.acidout 5 -39.7±7.3  
3.0±0.8 
 
0.7±0.7 
 
16.4±0.8 
 
17.0±0.8 
 
AA+GSHin/ 
asc.acidout 
4 -17.1±1.3%  
4.4±1.1 
 
2.8±1.0 
 
18.4±1.0 
 
17.8±0.9 
 
control Troloxin 5 -39.4±10.8  
0.5±0.9 
 
-4.5±0.7 
 
18.0±0.8 
 
17.1±0.6 
 
AA+Troloxin 7 -20.8±8.5%  
-3.2±0.9 
 
-1.2±1.0 
 
18.2±0.8 
 
19.4±0.9 
 
control Troloxout 4 -1.0±5.7  
-2.3±0.7 
 
-6.7±0.8 
 
17.7±0.6 
 
17.9±0.7 
 
AA+Troloxin/ 
Trolox out 
4 -18.4±10.6%  
-3.3±1.1 
 
-1.0±1.0 
 
19.3±1.0 
 
16.7±0.9 
 
+80µM H2O2 7 -63.2±5.1%  
1.4±1.5 
 
-5.7±1.5 
 
11.3±1.4 
 
12.5±1.3 
 
H2O2 +GSHin 4 -21.1±5.3%  
-3.3±1.1 
 
-6.7±1.2 
 
19.2±1.0 
 
17.6±1.0 
 
H2O2+GSHin/ 
asc.acidout 
4 -23.0±3.9%  
3.5±0.8 
 
-8.2±0.9 
 
17.7±0.7 
 
17.7±0.8 
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Oxidative modulation of transient and delayed rectifier potassium 
currents in ECLIII pyramidal neurons 
Potassium currents in untreated ECLIII pyramidal neurons 
In whole-cell patch–clamp experiments with pyramidal neurons in layer III from medial 
entorhinal cortex the membrane potential of the cells were hyperpolarized to -110 mV for 800 
ms from holding potential of -80 mV (for protocols see insets Fig.22). Depolarizing command 
pulses of 200 ms duration between -80 and + 50 mV (every 10 mV) elicited families of 
potassium outward currents, that are depicted here on Fig.22 A and B. With the above 
described subtracting procedure (see p. 35), the transient and delayed rectifier potassium 
currents were further separated. The isolated transient potassium current IA had an amplitude 
of 0.5-4 nA and inactivated fast with a time constant of 13.0 ± 3.7 ms. IA maximal amplitude 
showed no changes within 15 min. after opening the cells (-1.2 ± 7.2 %, n=9, Fig.22 C and 
Fig.23 A, black line). The time constant of inactivation of IA was diminished after 15 min to 
9.0 ± 3.5 ms (Fig.22 C, Table 7) however this difference was not statistically significant. 
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Fig. 22 Native IA and IK(V)  in control condition in ECLIII pyramidal neurons. 
 A, B Original traces showing total outward potassium (IK(V)+IA) and delayed rectifier (IK(V)) currents 
at 0 s (A) and 900 s (B) after reaching whole-cell configuration. C Subtracted transient potassium 
current (IA) recorded at +30 mV over time. D, Delayed rectifier current at +30 mV over time. 
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As shown on Fig.23 D and Fig.24 A and C (black line) and D, IK(V) had maximal amplitude of 
2 to 9 nA in control conditions which remained relatively stable (-10.5 ± 4.3 %, n=9) during 
an experiment of 15 min duration. 
 
Modulation of transient IA and delayed rectifier currents IK(V) by 
arachidonic acid 
Application of 1 pM intracellular arachidonic acid to ECLIII pyramidal neurons strongly 
reduced the transient potassium current amplitude from -1.2 ± 7.2% in control to -57.9 ± 7.2 
% after 15 min with AA in the pipette (Fig.23 A, red line; C). Arachidonic acid insignificantly 
slowed down IA inactivation kinetics from 8.8 ± 1.6 to 12.9 ± 1.9 ms (Table 7).  
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Fig. 23 Suppression of IA by arachidonic acid (AA) in ECLIII pyramidal neurons. 
 A: control; B, C: Intracellular application of 1 pM AA reduces the maximal transient potassium 
current (IA) over time. The non-metabolizable AA analogue ETYA shows similar effect on IA at 100-
fold higher concentration (C). D, E: Raw current traces for combined IA and I k(v) and for delayed 
rectifier currents (pulse protocols: inset in E). Currents are shown for control immediately after 
obtaining whole cell configuration (D, 0 s AA), after and after 900 s of recording with 1 pM of AA in 
the patch pipette (E). 
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100 pM intracellularly applied ETYA mimicked the effect of 1 pM arachidonic acid, as 
shown on Fig.23 A, green line. This fact qualifies the effect of AA in ECLIII pyramidal 
neurons as direct, as ETYA blocks the enzymes from the arachidonic acid metabolitic 
pathway. This effect was already shown for CA1 pyramidal neurons (see p.40).  
In contrast to IA, IK(V) was found to be less sensitive to 1 pM AA (Fig.24). Its maximal 
amplitude in ECLIII pyramidal neurons was reduced by 19.7 ± 8.7 % (n=9). 
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Fig. 24 The delayed rectifier current I k(v) is not affected by AA in ECLIII pyramidal 
neurons.  
A, B: Maximal Ik(v) recorded at 0 s and at 900 s of whole cell recording shows a ~ 10% decrease over 
time in control (A) and ~ 20% decrease with 1 pM AA in the patch pipette (B). C: Plot of Ik(v) 
amplitude over time of whole cell recording for control and for AA. D, E: Original current recordings 
of Ik(v) for several voltage steps (see inset in C) for control (D) and for AA at 0 s (D1, E1) and 900 s 
(D2, E2) of whole cell recording. 
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In ECLIII, as well as in CA1 pyramidal neurons, the activation and steady-state inactivation 
kinetics of the isolated IA and IK(V) were best fitted with Boltzmann equations. Resulting 
curves revealed that IA in control conditions is activated at ~ -60 mV and saturated at 
potentials more positive than +20 mV. IA in control had a V50 of -18.2 ± 1.3mV and slope 
factor (k) of 16.0 ± 1.1. Inclusion of 1 pM AA to the patch pipette led to insignificant change 
of V50 and the slope factor of activation kinetic of IA (V50 = -21.4 ± 1.0 mV and k= 8.6 ± 0.9). 
In contrast, the steady-state inactivation of IA was shifted with ~11 mV to hyperpolarizing 
direction (Fig.25 A) after application of 1pM AA (Table 7). AA also significantly shifted the 
activation half-maximal voltage V50 of IK(V) from 5.7 ± 0.3 mV to -1.9 ± 0.5 mV (Fig.25 C). 
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Fig. 25 Intracellular AA shifts steady-state inactivation, but does not affect voltage 
dependence of activation of IA in ECLIII pyramidal neurons.  
A: Conductance-voltage relations and Boltzmann fits for inactivation (left curves) and activation (right 
curves) of IA. Inset: Pulse protocols for determining voltage dependence of steady state inactivation 
(left) and of activation (right). Red part shows length of the traces below. B and C: Representative 
recordings for inactivation (B) and activation (C).D: voltage-conductance dependence of IK(V) and 
pulse protocols for activation of IK(V) (inset). E: Original recordings of IK(V) activation in control 
conditions and in the presence of 1 pM AA. 
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Influence of glutathione on arachidonic acid-mediated effects  
Intracellular GSH (20 mM), applied together with 1 pM AA further decreased IA in ECLIII 
pyramidal neurons (Fig. 26 A, blue line), as reported for CA1 neurons. In agreement with this 
data, incubation of the slices for 2 hours prior to experiment with NAC ( N-acetyl-L-cysteine, 
precursor of GSH) could not prevent the effect of arachidonic acid on IA in ECLIII pyramidal 
neurons (data not shown). Additionally, GSH slowed down the inactivation of IA from 10.3 ± 
3.4 to 17.3 ± 2.8 ms, as seen on Fig.26 B1. 
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Fig. 26 Interaction of AA, GSH and ascorbic acid with IA in ECLIII pyramidal neurons.  
A, B: GSHi enhances the AA effect on IA (A: blue line; B1), particularly early after begin of 
application (*). As well, ascorbic acid could not block the AA effect (A: green line; B2). C, D: GSHi 
and ascorbic acido both prevent the AA-mediated shift in steady-state inactivation (C, D, control=0 s 
vs. 900 s, left curves) but GSH slightly shifts the activation curve to more positive potential (D, right 
curves).  
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Influence of glutathione and ascorbic acid on arachidonic acid-mediated effects  
Yet, addition of ascorbic acid at concentrations up to 0.4 mM to the bath failed to remove 
effects of AA on the maximal IA amplitude (Fig.26 A, green line), which is in contrast to the 
results obtained for CA1 pyramidal neurons, although it prevented GSH-mediated slow-down 
of this current (Fig.26 B2). 
However, reduced glutathione, applied intracellularly, did significantly block the AA-induced 
shift of steady-state inactivation (Fig.26 D). Moreover, it shifted the activation V50 of IA from 
-15.5 ± 0.7 mV to -25.8 ± 0.9 mV, as the slope factor k remained unaffected (Table 7). The 
triple combination treatment of AA and the antioxidants ascorbic acid and GSH, resulted 
again in blocked arachidonic acid effect on the steady-state inactivation of the transient 
potassium channels (Fig.26 C). IK(V) in the presence of AA+GSHin reached 99.3 ± 9.7 % of 
control amplitude. Further perfusion of the slice with ascorbic acid led to IK(V) with maximal 
amplitude of 76.8 ± 6.6% and shifted IK(V) voltage–conductance relation of activation towards 
more negative potentials by ~15 mV (from -2.2 ± 0.8 mV to -17.6 ± 1.3 mV, n=6). 
Influence of Trolox on arachidonic acid-mediated effects  
Trolox, applied only on the inner side of the cell membrane, blocked completely the reduction 
of IA by arachidonic acid (Fig.27 A, blue line). Troloxin did fail in preventing AA-mediated 
shift in inactivation and changed the activation parameters from V50= -27.0 ± 0.4 mV and 
k=9.7 ± 0.4 to V50= -21.8 ± 0.7 mV and k=12.2 ± 0.6 (Fig.27 C). In comparison, Trolox on 
both sides of the membrane accelerated the early AA effect, in GSH-like manner. It did not 
block the leftward shift of the steady-state inactivation curve, caused by 1pM arachidonic 
acid, but it shifted the activation kinetic by ~10 mV in depolarizing direction as shown on 
Fig.27 D. No significant changes on the time constant of inactivation of IA in both cases with 
Trolox were observed (Table 7). On the other hand, Trolox, independently of the site of 
application, fully inhibited AA effect on the maximal amplitude of IK(V) (Table 8). 
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Fig. 27 Interaction of AA and Trolox with IA in ECLIII pyramidal neurons.  
A, B: Intracellular application of the vitamin E analogue Trolox (10 µM) with AA (A1, B: blue line) 
did significantly recover IA, but Trolox, applied from both sides of the cell membrane, did not prevent 
reduction of IA (A2, B: green line). C: Troloxi did not inhibit the AA shift of steady-state inactivation 
(left curves). There is shift in voltage dependence of activation (right curves, control=0 s vs. 900 s). D: 
In the presence of Trolox on both sides of the membrane plus AAi, steady state inactivation shifts over 
900 s recording time by -12mV to more negative potential, as well as activation mV to more positive 
potential, similar to the effect of Troloxi.  
 
 
Effects of H2O2 on outward potassium currents 
As observed for CA1 pyramidal neurons, H2O2 mimics the effect of AA on maximal IA in 
ECLIII pyramidal neurons (Fig.28 A, red line). 
H2O2 did shift voltage conductance relations of inactivation to more negative and activation to 
more positive potentials (Fig.28 B). Mean parameters were: for activation, V50= -24.9 ± 1.7 
mV; k=14.2 ± 1.5 and for inactivation, V50= -53.6 ± 0.6 mV; k=11.3 ± 0.5 (n=7). 
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Influence of glutathione and ascorbate on H2O2–mediated effects on potassium 
currents 
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Fig. 28 Effects of intracellular H2O2 (80 µM) and antioxidants on IA in ECLIII 
pyramidal neurons.  
A: H2O2 mimics the effect of AA on maximal IA. This effect is not inhibited by GSHi or by 
GSHi+ascorbic acido. B: Voltage conductance relations of inactivation (left curves) and activation 
(right curves) in the presence of H2O2. C: GSHi does not eliminate the H2O2 mediated shift in 
inactivation (left curves), but leads to further shift of activation (right curve). D: Steady-state 
inactivation (left curves) and activation (right curves) kinetics of IA in the presence of ascorbic acido, 
GSHi and H2O2. E: Representative current traces of IA for determination of the voltage dependence of 
activation for control immediately after obtaining whole cell configuration (E1) and after 900 s of 
recording with H2O2 in the patch pipette (E2). 
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As seen on Fig.28 C, GSHi does not eliminate the H2O2 mediated shift in inactivation, but 
augments the rightward shift of the steady state activation curve. In the presence of H2O2, 
GSHi and ascorbic acido, the steady-state inactivation and activation kinetics of IA were not 
significantly different from those for H2O2 alone (Fig.28 D). 
The delayed rectifier current from ECLIII pyramidal neurons is sensitive to H2O2, as already 
shown for CA1 pyramidal neurons. H2O2 reduced IK(V) by 26.3 ± 5.5 %, n=7 (Fig.29 A, red 
line). Intracellular GSH as well as GSH in combination with ascorbic acid, reduced the effect 
of H2O2 on the maximal amplitude to -3.7 ± 8.6 %, n=8 and -12.7 ± 7.7 %, n=6 (Fig.29 A, 
blue and green lines), respectively. Although a change in the activation voltage dependence of 
IK(V) in the presence of H2O2 was not observed (Fig.29 B), application of antioxidants on one 
or both sides of the membrane shifted it to more negative values. GSHin caused a small, but 
significant shift from -5.7 ± 0.7 mV to -11.3 ± 1.5 mV, and moreover, changed the slope 
factor k from 17.8 ± 0.6 to 22.8 ± 1.4, n=8. In the case of GSHin and ascorbic acidout the shift 
of the steady state activation curve was large, with V50 of about ~20 mV (from -0.1 ± 0.9 mV 
to -22.0 ± 1.5 mV, n=6), while the slope of the steady-state activation curve remained 
unaltered (Table 8). 
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Fig. 29 Effects of intracellular H2O2 (80 µM) and antioxidants on IK(V) in ECLIII 
pyramidal neurons. 
 A: H2O2 suppresses the delayed rectifier potassium current IK(V) (red line), and this effect is inhibited 
by GSHi or GSHi+ascorbic acido (blue and green lines, respectively). B: H2O2 does not shift voltage 
dependence of activation of IK(V). C, D: Representative traces of IK(V) for determination of voltage 
dependence of activation for control immediately after obtaining whole cell configuration (C1, D1, 0 
s) and after 900 s recording with H2O2 (C2) or H2O2 + GSHi in the patch pipette (D2). Recordings of D 
have been obtained in the presence of ascorbic acido. 
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Table 7 Overview of effects of oxidants and antioxidants on behavior parameters of IA 
in ECLIII pyramidal neurons. 
 
 
I A  
ECLIIIpn 
 
n 
max 
amplitude, 
% of 
control 
V 50a 
0 min  
mV 
V 50a 
15 min  
mV 
kactivation 
0 min 
ka 
15 min 
V 50i  
0 min
mV 
V 50i  
15 min
mV 
kinactivation 
0 min 
ki 
15 min 
τi 
0 min  
ms      
τi      
15 min   
ms       
control 9 -1.2±7.2%  
-21.0±1.5 
 
-18.2±1.3
 
15.6±1.3 
 
16.0±1.1 
 
-52.2±0.9
 
-50.8±1.0
 
15.2±0.8 
 
15.8±1.1 
 
13.0±3.7
 
9.0±3.5 
 
+ 1pM AA 9 -57.9±7.2%  
-18.7±0.7 
 
-21.4±1.0
 
8.9 ±0.7 
 
8.6 ±0.9 
 
-44.4±0.8
 
-53.3±1.6
 
9.8 ±0.7 
 
10.7±1.5 
 
8.8 ±1.6 
 
12.9 ±1.9 
 
AA+GSHin 6 -66.3±4.4%  
-15.5±0.7 
 
-25.8±0.9
 
12.9±0.8 
 
12.6±0.8 
 
-49.5±0.3
 
-53.6±0.6
 
9.8±0.3 
 
11.2±0.5 
 
10.3±3.4
 
17.3±2.8 
 
control 
asc.acidin 
6 -41.9±9.5%  
-18.7±1.3 
 
-18.3±1.9
 
15.9±1.1 
 
16.4±1.7 
 no data no data no data no data 
17.4±6.4
 
17.7±7.1 
 
AA+GSHin/ 
asc.acidout 
6 -60.7±10.0%  
-18.1±0.4 
 
-19.2±0.9
 
7.8±0.4 
 
8.1±0.8 
 
-49.5±0.3
 
-54.0±0.8
 
9.8±0.3 
 
11.9±0.7 
 
6.4±1.4 
 
7.1±1.9 
 
AA+Troloxin 7 -16.2±3.9%  
-27.0±0.4 
 
-21.8±0.7
 
9.7±0.4 
 
12.2±0.6 
 
-45.5±0.5
 
-54.0±0.8
 
11.0±0.4 
 
10.7±0.7 
 
7.0±2.5 
 
9.5±2.1 
 
AA+Troloxin, 
out 
6 -56.1±5.4%  
-26.3±0.9 
 
-15.3±0.7
 
12.9±0.8 
 
12.9±0.6 
 
-46.3±0.8
 
-57.4±0.7
 
11.0±0.7 
 
9.0±0.6 
 
3.6±0.4 
 
4.6±0.5 
 
+80µM H2O2 7 -53.0±4.1%  
-31.7±1.0 
 
-24.9±1.7
 
9.9±0.8 
 
14.2±1.5 
 
-41.4±0.3
 
-53.6±0.6
 
10.2±0.3 
 
11.3±0.5 
 
3.3±0.5 
 
3.2±0.5 
 
H2O2 +GSHin 8 -70.7±8.7 %  
-29.3±1.0 
 
-20.1±1.5
 
9.5±0.9 
 
15.9±1.3 
 
-53.1±0.7
 
-63.6±0.6
 
11.3±0.6 
 
11.3±0.6 
 
9.9±2.7 
 
5.2±1.2 
 
H2O2+GSHin/ 
asc.acidout 
6 -57.3±3.7 %  
-20.8±0.6 
 
-17.1±1.0
 
12.2±0.5 
 
17.6±0.9 
 
-62.9±0.5
 
-73.5±0.6
 
11.2±0.4 
 
9.9±0.6 
 
4.9±1.5 
 
9.8±2.8 
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Table 8 Overview of effects of oxidants and antioxidants on behavior parameters of 
IK(V) in ECLIII pyramidal neurons. 
 
 
I k(v)   ECLIIIpn n max amplitude  
% of control 
V50activation  
0 min 
V50a  
15 min 
kactivation  
0 min 
ka  
15 min 
control 9 -10.5±4.3 %  
-10.7±1.3 
 
-12.8±1.3 
 
19.5±1.5 
 
19.4±1.1 
 
+ 1pM AA 9 -19.7±8.7 %  
5.7±0.3 
 
-1.9±0.5 
 
18.1±1.1 
 
19.9±0.7 
 
AA+GSHin 6 -0.7±9.7 %  
1.5±1.2 
 
-0.9±0.6 
 
18.5±0.9 
 
17.2±0.6 
 
control asc.acidin 6 -36.3±6.5 %  
-8.8±1.3 
 
-10.4±1.3 
 
19.7±1.1 
 
19.3±1.0 
 
AA+GSHin/ 
asc.acidout 
6 -23.2±6.6 %  
-2.2±0.8 
 
-17.6±1.3 
 
18.9±0.7 
 
22.1±1.2 
 
AA+Troloxin 7 -4.1±10.2 %  
1.1±0.8 
 
2.4±0.8 
 
14.3±0.7 
 
15.8±0.7 
 
AA+Troloxin/ 
Trolox out 
6 -7.9±6.5 %  
-7.5±1.1 
 
-2.7±0.8 
 
21.1±1.0 
 
17.1±0.7 
 
+80µM H2O2 7 -26.3±5.5 %  
-18.1±0.4 
 
-19.2±0.9 
 
16.1±0.6 
 
17.9±0.8 
 
H2O2 +GSHin 8 -3.7±8.6 %  
-5.7±0.7 
 
-11.3±1.5 
 
17.8±0.6 
 
22.8±1.4 
 
H2O2+GSHin/ 
asc.acidout 
6 -12.7±7.7 %  
-0.1±0.9 
 
-22.0±1.5 
 
16.3±0.8 
 
19.1±1.3 
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Oxidative modulation of transient and delayed rectifier potassium 
currents in ECLII stellate neurons 
Potassium currents in untreated ECLII stellate cells 
Step depolarization of the membrane potential (protocols: inset Fig.30 B) of LII stellate 
neurons from the entorhinal cortex activated large outward potassium currents (0.5-13 nA) 
that are illustrated in Fig. 30 A. Digital subtraction of the sustain component (IK(V)) revealed 
robust transient potassium current IA that was stable during the course (15 min.) of the 
experiment (-11.8 ± 4.7 % from control, n=9, Fig.29 C). Analysis of the delayed rectifier 
current also showed stability of IK(V) over 15 min. (-12.7 ± 7.6 %, n=9, Fig.30 D). 
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Fig. 30 Native IA and IK(V)  in control condition in ECLII stellate neurons.  
A, B Original traces showing total outward potassium (IK(V) + IA) and delayed rectifier (IK(V)) currents 
at 0 s (A) and 900 s (B) after reaching whole-cell configuration. C Subtracted transient potassium 
current (IA) recorded at +30 mV over time. D Delayed rectifier current at +30 mV over time. 
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Modulation of transient IA and delayed rectifier currents IK(V) by 
arachidonic acid 
1pM intracellular arachidonic acid reduced the subtracted IA current by -66.3 ± 9.6 %, n=10 
within 15 min. (Fig.31 A, red line). ETYA, inhibitor of the enzymes that metabolize AA and 
triple-bond analogue of arachidonic acid, required higher concentration (100 pM) to mimic 
the effect of 1 pM AA (Fig.31 A, green line). However, this effect tended to develop faster (in 
the first 3 min.) which is probably the result of the higher concentration of ETYA. 
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Fig. 31 Suppression of IA by arachidonic acid (AA) in ECLII stellate cells.  
A (black line), B: control; A, C: Intracellular application of 1 pM AA reduces the maximal transient 
potassium current (IA) over time. The non-metabolizable AA analogue ETYA shows similar effect on 
IA at 100-fold higher concentration. D, E: Raw current traces for combined IA and Ik(v) and for pure 
delayed rectifier currents (pulse protocols: inset in E).Currents are shown for control immediately after 
obtaining whole cell configuration (D, 0 s AA) and after 900 s of recording with 1 pM of AA in the 
patch pipette (E). 
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An additional effect of 1 pM AA was an 11 mV leftward shift of the steady-state inactivation 
curve with a slight change of the slope factor (from V50= -42.8 ± 0.4 mV; k= 9.2 ± 0.6 to V50= 
-55.1 ± 0.7 mV; k= 12.4 ± 0.6, n=10; Fig.32 A, left curves). AA did not affect the time 
constant of IA inactivation. The steady state activation curve of IA was also shifted to the left 
by ~6mV and the slope factor changed from 9.1 ± 0.5 to 13.7 ± 0.7 (Fig.32 A, right curves).  
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Fig. 32 Intracellular AA shifts steady-state inactivation, but does not affect voltage 
dependence of activation of IA in ECLII stellate neurons.  
A: Conductance-voltage relations and Boltzmann fits for inactivation (left curves) and activation (right 
curves) of IA. Inset: Pulse protocols for determining voltage dependence of steady state inactivation 
(left) and of activation (right). Red part shows length of the traces below. B: Representative recordings 
of transient potassium current for control (B1) and in the presence of 1 pM AA (B2). C: Voltage-
conductance dependence of IK(V) and pulse protocols for activation of IK(V) (inset). D: Original 
recordings of IK(V) activation in control conditions (D1) and in the presence of 1 pM AA (D2). 
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Like in ECLIII pyramidal neurons, arachidonic acid had a modest, but significant effect on 
the delayed rectifier current in ECLII stellate cells (Fig.33 B, E). As in ECLIII pyramidal 
neurons, 1 pM AA suppressed IK(V) by -29.1 ± 6.7 %, n=10 (Fig.33 C). This suggests that this 
effect is probably specific to the delayed rectifier current in the entorhinal cortex. 
However, 1 pM arachidonic acid did not alter the voltage dependence of activation of the 
delayed rectifier current in ECLII stellate neurons (Fig.33 C). 
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Fig. 33 The delayed rectifier current I k(v) is not affected by AA in ECLII stellate 
neurons.  
A, B: Maximal Ik(v) recorded at 0 s and at 900 s of whole cell recording shows a 13% decrease over 
time in control (A) and 30 % decrease with 1 pM AA in the patch pipette (B). C: Plot of Ik(v) amplitude 
over time of whole cell recording for control and for AA. D, E: Original current recordings of Ik(v) for 
several voltage steps (see inset in C) for control (D) and for AA at 0 s (D1, E1) and 900 s (D2, E2) of 
whole cell recording. 
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Influence of glutathione on arachidonic acid-mediated effects 
Glutathione (20 mM), added to AA in the patch pipette failed to block the AA-mediated 
decrease of the maximal amplitude of the transient current (-75.6 ± 9.3 %, n=6 compared to -
66.3 ± 9.6 %, n=10). Moreover, GSHin+AA significantly reduced the IA current within first 3 
min. of the experiment (Fig.34 A, blue line, *). GSHin did not prevent the leftward shift of 
voltage dependence of inactivation, caused by 1pM AA (Fig.34 D, left curves), but slowed the 
kinetic of inactivation of the transient potassium current (Table 9). 
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Fig. 34 Interaction of AA, GSH and ascorbic acid with IA in ECLII stellate neurons. 
A, B: GSHi (A: blue line, B1), as well as ascorbic acid (A: green line, B2) enhanced the AA effect on 
IA, particularly early after begin of recording/application (*). C, D: GSHi and ascorbic acido do not 
prevent the AA-mediated shift in steady-state inactivation (C, D, control=0 s vs. 900 s, left curves). 
Ascorbic acid further shifts the inactivation curve to more negative potential and changes its slope (C, 
left curves). 
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Influence of glutathione and ascorbic acid on arachidonic acid-mediated effects 
Addition of 4 mM ascorbic acid to the perfusion solution (AA and GSH in the patch pipette) 
resulted in effects similar to those of GSHin and AA: slowed inactivation (Fig.34 B2), 
acceleration of the AA effect on the maximal conductance, no change of the voltage 
dependence of activation, large (V50= -41.4 ± 0.4 mV vs. -55.4 ± 1.9 mV, n=6) shift of the 
steady-state inactivation to more negative potentials (Fig.34 A: green line, C).  
On one hand, GSH on the inner side of the cell membrane did not result in significant 
attenuation of the AA effect on the maximal amplitude of the delayed rectifier current (-19.8 
± 8.9 % , n=6 vs. -29.1 ± 6.7 %, n=10). On the other hand, in addition to GSH, ascorbic acid 
on the outer side of the membrane did reduce the maximal amplitude of IK(V) to -10.0 ± 11.6 
%, n=6 and also changed V50 (from -7.9 ± 0.8 mV to -16.4 ± 1.4 mV) and the slope factor 
(from 16.8 ± 0.7 to 22.0 ± 1.3) of the voltage dependence activation of IK(V) (Table 10). 
 
Influence of Trolox on arachidonic acid-mediated effects 
The vitamin E-based antioxidant Trolox C, on the inner membrane of the ECLII stellate 
neurons, failed to block the arachidonic acid effect on the maximal amplitude of the transient 
potassium current, -74.3 ± 0.7 % vs. -66.3 ± 9.6 %, n=6 (Fig.35 A: blue line), but it was 
successful in blocking the effect of AA on the voltage dependence of steady-state inactivation 
and activation and their slopes (Fig.35 C). Trolox, applied through the pipette and through the 
bath, tended to slightly reduce the effect of AA (-60.4 ± 3.5 % vs. -66.3 ± 9.6 %, n=8) at late 
recording time, however this result is not statistically significant (Fig.35 A: green line). It also 
blocked the effect of 1 pM AA on the steady-state inactivation kinetic and further shifted it by 
~10 mV to more positive potentials (Fig.34 D). Trolox, applied on the both sides of the 
membrane, block the effect of AA on the voltage-conductance relation of the IA activation, 
but not the effect on its slope (Fig.35 D). Moreover, it did accelerate the kinetic of 
inactivation of IA (Fig.35 B2). Interestingly, Trolox, applied both through pipette and 
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perfusion or only through the patch pipette accelerated the effect of 1 pM arachidonic acid on 
the maximal conductance of IA (Fig.35 A). 
Troloxin reduced the effect of 1pM AA on the maximal amplitude of the delayed rectifier 
current from -29.1 ± 6.7 % to -18.9 ± 4.9 % and shifted it activation voltage dependence by 
~6 mV more negative potentials (Table 10). No changes of the slope of the voltage 
dependence of activation were observed. Trolox in/out, did not block the reducing effect of AA 
on the IK(V) maximal amplitude (-33.7 ± 6.8 % vs. -29.1 ± 6.7 %, n=8). It shifted the voltage 
dependence of IK(V) activation by ~5 mV to the left, without affecting its slope (Table 10). 
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Fig. 35 Interaction of AA and Trolox with IA in ECLII stellate neurons.  
A, B: Intracellular application of the vitamin E analogue Trolox (10 µM) with AA does not prevent 
reduction of IA (A: blue line, B1). Trolox, applied from both sides of the cell membrane, does 
unsignificantly recover IA with prolonged recording time (A: green line, B2). C: Troloxi inhibits the 
AA shift of steady-state inactivation (left curves). There is no shift in voltage dependence of activation 
(right curves, control=0 s vs. 900 s). D: In the presence of Trolox on both sides of the membrane plus 
AAi, steady state inactivation shifts over 900 s recording time by -10 mV to more positive potential. 
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Effects of H2O2 on outward potassium currents 
As an oxidative damage model system to compare the effects of AA, the effect of H2O2 on the 
transient potassium and delayed rectifier channels was used. To obtain an effect, similar to 
that of 1 pM AA on the maximal amplitude of IA and IK(V), 80 µM H2O2 was required (Fig.36 
A: red line). 
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Fig. 36 Effects of intracellular H2O2 (80 µM) and antioxidants on IA in ECLII stellate 
neurons. 
 A: H2O2 mimics the effect of AA on maximal IA (red line). This effect is enhanced early by GSHi and 
in the presence of ascorbic acido does not differ from those for H2O2 (blue and green line, 
respectively). B: H2O2 shifts voltage conductance relations of inactivation (left curves) to more 
negative potentials as well as changes the slope of activation and inactivation curves. C: GSHi 
diminishes the H2O2 mediated shift in inactivation (left curves), but for activation causes a slight shift 
to more positive potential. D: In the presence of ascorbic acido, GSHi + H2O2 shift inactivation and 
activation of IA back by -12 mV to more negative potentials. E: Representative current traces of IA for 
determination of the voltage dependence of activation for control immediately after obtaining whole 
cell configuration (E1) and after 900 s of recording with H2O2 in the patch pipette (E2). 
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H2O2 reduced the maximal amplitude of IA by -64.4 ± 3.8 %, shifted leftwards the the steady-
state inactivation curve leftward by ~12mV, but did not affect significantly the rate of IA 
inactivation (Fig.36 A, B). Those effects are consistent with the effects of 1 pM arachidonic 
acid on the transient potassium current characteristics in ECLII stellate neurons (Table 9). In 
the presence of H2O2, the voltage dependence of activation of IA was did not change, but 
slope factor was altered from 10.9 ± 0.3 to 13.9 ± 0.9, n=8 (Fig.36 B). 
 
Influence of glutathione and ascorbic acid on H2O2-mediated effects 
Application of GSH through the patch pipette resulted in stronger attenuation of the IA current 
during the first 6 min. of the experiment (Fig.36 A: blue line), an effect previously observed 
in other types of neurons (see p.43 and p. 59). In general, the effect of H2O2 on the maximal 
amplitude of the transient potassium current could be blocked neither by GSH, nor by 
addition of ascorbic acid to the bath (Fig.36 A). Intracellular GSH decreased the leftward shift 
in voltage dependence of inactivation from ~12 mV to ~7 mV (Fig.36 C). GSHin did not block 
the right shift of voltage dependence of activation, but abolished the slope effect. With GSHin 
and AA, the time constant of inactivation of IA in ECLII stellate cells was reduced from τi=7.8 
± 1.1 ms to τi=4.8 ± 1.3 ms (n=4). Addition of ascorbic acid to the perfusion solution did not 
block H2O2-induced ~12mV left shift of the voltage dependence of inactivation of IA (-44.0 ± 
0.5 mV vs. -55.7 ± 0.6 mV, n=8), did not alter the voltage-conductance relation for activation 
and accelerated the rate of IA inactivation kinetics (Fig.36 D, Table 9).  
As seen on Fig.37 A, H2O2 suppressed the delayed rectifier current to an extent, which was 
similar to that of 1 pM arachidonic acid (-22.2 ± 9.1 % and -29.1 ± 6.7 %, respectively). 
However, 80 µM H2O2 caused a small (~6mV), albeit significant shift of IK(V) voltage 
dependence of steady-state inactivation to more negative potentials (Fig.37 B). Intracellular 
GSH blocked the effect of H2O2 on the maximal conductance of IK(V) (-12.3 ± 9.6 %, n=4), as 
did GSHin, combined with asc.acidout (-14.1 ± 5.1 %, n=8), but these effects seemed not to be 
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statistically significant. Glutathione, applied on the inner side of the neuronal membrane led 
to a ~3 mV shift to hyperpolarizing direction of the voltage dependence of activation of IK(V) 
with small change of the slope (from 17.4 ± 0.7 to 19.5 ± 1.0, n=8). Ascorbic acid, in the 
presence of GSH and AA shifted the voltage dependence of activation of IK(V) from V50= -5.9 
± 1.0 mV to V50= -14.2 ± 1.1 mV, without affecting its slope (Table 10). 
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Fig. 37 Effects of intracellular H2O2 (80 µM) and antioxidants on IK(V) in ECLII stellate neurons.  
A: H2O2 suppresses the delayed rectifier potassium current IK(V), and this effect is fully inhibited by 
GSHi or GSHi+ascorbic acido (blue and green line, respectively). B: H2O2 insignificantly shifts voltage 
dependence of activation of IK(V) to a more negative potential. C, D: Representative traces of IK(V) for 
determination of voltage dependence of activation for control immediately after obtaining whole cell 
configuration (C1, D1, 0 s) and after 900 s recording with H2O2 (C2) or H2O2 + GSHi in the patch 
pipette (D2). Recordings of D have been obtained in the presence of ascorbic acido. 
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Table 9 Overview of effects of oxidants and antioxidants on behavior parameters of IA in 
ECLII stellate neurons. 
 
 
I A ECLIIst  
n 
max 
amplitude, 
% of 
control 
V 50a 
0 min  
mV 
V 50a 
15 min  
mV 
kactivation 
0 min 
ka 
15 min
V 50i  
0 min
mV 
V 50i  
15 min
mV 
kinactivation 
0 min 
ki 
15 min 
τi 
0 min  
ms      
τi      
15 min   
ms      
control 9 -11.8±4.7%  
-12.2±1.0 
 
-14.3±0.3 
 
9.0±0.9 
 
7.9±0.3 
 
-45.3±0.8
 
-48.8±0.5 
 
9.5±0.7 
 
7.7±0.4 
 
8.6±2.3 
 
9.2±2.1 
 
+ 1pM AA 10 -66.3±9.6%  
-17.8±0.5 
 
-23.7±1.8 
 
9.1±0.5 
 
13.7±0.7
 
-42.8±0.4
 -55.1±0.7 
9.2±0.6 
 
12.4±0.6 
 
6.6±2.7 
 
7.4±2.9 
 
AA+GSHin 6 -75.6±9.3%  
-32.1±0.7 
 
-28.5±0.9 
 
12.8±1.6 
 
11.3±1.3
 
-45.8±0.8
 
-56.2±0.8 
 
9.7±0.5 
 
10.5±0.7 
 
12.0±2.3
 
18.6±2.5
 
AA+GSHin/ 
asc.acidout 
6 -71.3±12.1%  
-18.1±0.4 
 
-21.5±1.2 
 
7.8±0.4 
 
9.5±1.0 
 
-41.4±0.4
 
-55.4±1.9 
 
10.2±0.5 
 
18.3±1.7 
 
3.6±0.6 
 
6.2±0.5 
 
AA+Troloxin 6 -74.3±0.7%  
-22.0±0.7 
 
-16.9±0.5 
 
10.1±0.6 
 
9.6±0.4 
 
-40.7±0.8
 
-46.7±1.3 
 
12.5±0.7 
 
12.4±1.1 
 
9.1±5.9 
 
8.4±3.0 
 
AA+Troloxin, 
out 
8 -60.4±3.5%  
-23.4±0.9 
 
-22.9±1.5 
 
13.5±0.8 
 
17.7±1.3
 
-58.6±0.9
 
-48.9±0.9 
 
13.4±0.8 
 
12.1±0.8 
 
3.2±0.4 
 
5.3±0.9 
 
+80µM H2O2 4 -64.4±3.8%  
-11.2±0.4 
 
-7.4±1.0 
 
10.9±0.3 
 
13.9±0.9
 
-48.8±0.8
 
-60.1±0.9 
 
9.4±0.9 
 
11.1±0.8 
 
5.6±1.7 
 
5.3±1.4 
 
H2O2 +GSHin 4 -72.6±7.6%  
-25.5±1.0 
 
-18.4±1.3 
 
10.3±0.8 
 
10.5±0.7
 
-45.2±0.9
 
-53.8±0.9 
 
10.8±0.5 
 
11.2±0.4 
 
7.8±1.1 
 
4.8±1.3 
 
H2O2 +GSHin/ 
asc.acidout 
8 -69.3±4.6%  
-9.2±1.1 
 
-7.6±0.8 
 
14.7±1.0 
 
13.3±0.7
 
-44.0±0.5
 
-55.7±0.6 
 
10.5±0.5 
 
11.6±0.5 
 
7.5±0.9 
 
5.3±0.7 
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Table 10 Overview of effects of oxidants and antioxidants on behavior 
parameters of in ECLII stellate neurons IK(V). 
 
 
I k(v)    ECLIIst n max amplitude 
% of control 
V50activation 
0 min 
V50a  
15 min 
kactivation 
0 min 
ka  
15 min 
control 9 
 
-12.7±7.6 % 
 
-7.1±1.2 
 
-8.2±1.5 
 
18.3±0.7
 
18.7±0.6 
 
+ 1pM AA 10 -29.1±6.7 %  
-1.7±1.1 
 
-1.5±1.1 
 
17.3±1.0
 
16.9±1.0 
 
AA+GSHin 6 -19.8±8.9 %  
-18.1±0.4 
 
-21.5±1.2
 
8.7±0.4 
 
9.5±1.0 
 
AA+GSHin/asc.acidout 6 -10.0±11.6 %  
-7.9±0.8 
 
-16.4±1.4
 
16.8±0.7
 
22.0±1.3 
 
AA+Troloxin 6 -18.9±4.9 %  
-10.6±1.2 
 
-16.7±1.4
 
17.4±1.0
 
17.3±1.2 
 
AA+Troloxin/Trolox out 8 -33.7±6.8 %  
-22.9±1.3 
 
-30.5±1.2
 
21.1±1.2
 
24.8±1.1 
 
+80µM H2O2 4 -22.2±9.1 %  
-1.3±0.9 
 
-7.4±1.1 
 
16.3±0.8
 
17.6±1.0 
 
H2O2 +GSHin 4 -12.3±9.6 %  
-6.6±0.8 
 
-10.0±0.9
 
17.4±0.7
 
19.5±1.0 
 
H2O2+GSHin/asc.acidout 8 -14.1±5.1%  
-5.9±1.0 
 
-14.2±1.1
 
20.3±0.9
 
20.0±1.0 
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Functional expression of Kv1 and Kv4 α-subunit-induced K+- 
currents in HEK-293 cell line 
Whole-cell voltage-clamp recordings from untransfected or mock-transfected HEK-293 cells 
revealed endogenous voltage-gated outward potassium currents in response to depolarization 
to potentials positive to 0 mV. The amplitudes of these currents, however, were very small: 
(~50 pA), a similar current amplitude was measured at +30 mV in mock-transfected (EGFP) 
cells further revealing that expression of EGFP alone does not influence functional potassium 
current densities (Fig.38 A, B). Cell input resistances were in the range of 1-20 GΩ. Leak 
currents were always ≤ 50 pA at -80 mV and were therefore not corrected. 
Large outward potassium currents, however, were seen routinely after transfection of HEK-
293 cells with Kv1.4 or Kv4.2, alone or in combination with EGFP (Fig.38 C, D). 
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Fig. 38 Outward K+-currents in untransfected (A) or mock-transfected (EGFP alone, B), 
Kv1.4-transfected (C) and Kv4.2-transfected HEK-293 cells (D). 
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Voltage-gated potassium channel pore-forming (α) subunits of the Kv1 and Kv4 subfamilies 
are thought to be the molecular determinants of A-currents in the brain. Heterologous 
expression of these subunits in human embryonal kidney cell line, however, resulted in 
transient K+-currents that show quantitatively distinct time- and voltage-dependent properties 
to those recorded from brain neurons.  
Part of the experiments with Kv-transfected HEK-293 cells was performed in cells that were 
co-transfected with EGFP, and recordings were obtained only from EGFP-positive cells. The 
transfection efficiency was low (1-5%) and approximately 50% of EGFP-positive cells also 
expressed Kv1.4 or Kv4.2, as revealed by electrophysiological experiments with those cells. 
 
Modulation of transient potassium current by arachidonic acid and Trolox 
in heterologously expressed Kv1.4-α in HEK-293 cell line 
Transient potassium current in untreated Kv1.4-transfected HEK-293 cells 
Whole-cell outward potassium currents were activated during 200 ms-long depolarization 
steps to test potentials between -80 and +50 mV from a holding potential of -80 mV (pulse 
protocols: inset Fig.38). An 800 ms-long prepulse at -110 mV was performed in order to 
remove inactivation of IA. The mean ± SEM peak outward K+-current amplitudes in Kv-
transfected HEK cells at +30 mV were significantly (p<0.001) higher than those in 
untransfected or mock-transfected HEK-293 cells (Fig.38). For inactivating HEK A-currents, 
the maximal amplitude of the currents were recorded during the +30 mV steps following each 
conditioning prepulse from -120 mV to +20 mV (pulse protocols: see inset Fig.39, B2). 
As seen on Fig.39 A, B, in HEK-293 cells, transfected with Kv1.4 (and EGFP) large (5.5-11 
nA) outward potassium currents were evident. The amplitude of the peak current at +30 mV 
(maximal amplitude for each cell) was followed over 15 min and evolvement over time was 
plotted as shown on Fig. 39 C. The maximal amplitude of the transient potassium current in 
Kv1.4-transfected HEK cells did not change significantly under control conditions during the 
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course of a 15 min-recording (-12.1 ± 6.1 %, n=7). The A-currents from Kv1.4-transfected 
HEK-293 cells activated and inactivated fast (τi=51.7 ± 2.9 ms), but significantly slower as 
native IA currents from brain slice neurons (CA1 τi=7.8 ± 1.5 ms; ECLIII τi=13.0 ± 3.7 ms; 
ECLII τi=8.6 ± 2.3 ms). On Fig.39, A2 and B2, one can clearly see the atypical voltage–
conductance dependence for the steady-state inactivation curve of Kv1.4-potassium current in 
comparison to the native neuronal IA currents (for example Fig. 39 B1). Distorted voltage 
dependence of inactivation is probably due to lack of supplementary β-subunit and/or other 
auxiliary Kv-channel subunits and factors in HEK cells that could stabilize inactivation of IA 
channels. 
The amplitude of the peak currents at each test potential were measured and peak outward 
conductances were then calculated (using the K+ equilibrium potential of -92 mV) and 
normalized to the peak conductance at +30 mV in the same cell. Mean (± SEM) normalized 
peak conductances for control conditions were plotted as a function of test potentials in Fig 39 
D and best fitted with Boltzman monoexponential equation (see Materials and Methods, 
p.36). Kv1.4-currents activated at ~ -60 mV and reached steady-state at potentials positive to 
+30 mV. Although the mean (± SEM) voltages at which half of the channels are activated 
(V50a) derived from this fits at time=0s (-24.7 ± 2.4 mV) differ from V50a for time = 900 s (-
4.8 ± 1.8 mV), those differences are not statistically significant. Voltage-dependence of 
inactivation and the maximum amplitude in control conditions remain unchanged over 
recording time of 15 min (Fig.39 C, D; Table 11).  
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Fig. 39 Transient potassium current in Kv1.4-transfected HEK-293 cells.  
A, B: Original traces showing IA activation (A) and inactivation (B) at 0 s and 900 s (pulse protocols: 
inset A2, B2). C: Transient potassium current (IA) recorded at +30 mV over time in control condition. 
D: Voltage-conductance dependence of activation (right curves) and steady-state inactivation (left 
curves) of IA. 
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Modulation of IA by arachidonic acid in Kv1.4-transfected HEK-293 cells 
Application of 1 pM arachidonic acid through the patch-pipette decreased the Kv1.4-mediated 
A-currents, expressed in HEK293 cells by 71.4 ± 6.3 % (n=9; p<0.001). This robust response 
of Kv1.4 channels to 1pM AA was contradictory with the findings of Villarroel and Schwarz 
(see Villaroel and Schwarz, 1996).  
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Fig. 40 Suppression of Kv1.4- IA by arachidonic acid. 
A, B: Control activation (A1) and inactivation (B1) of IA (pulse protocols: inset A2, B2). Raw current 
traces of IA are shown for control immediately after obtaining whole cell configuration (A1, B1, 0 s 
AA) and after 900 s of recording with 1 pM of AA in the patch pipette (A2, B2, 900 s AA). C: 
Intracellular application of 1 pM AA (red line) reduces the maximal transient potassium current (IA) 
over time. D: Activation (left curves) and steady-state inactivation (right curves) kinetics in control 
condition (black symbols) and after application of 1 pM arachidonic acid through the pipette (red 
symbols). 
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As seen on Fig. 40 C, AA difused to the cytoplasm within 3 min. and reached full effect on 
the maximal amplitude of IA within 10 min.  
AA did not significantly alter the voltage-dependence of activation (V50a from -9.2 ± 1.4 mV 
to -5.2 ± 1.6 mV and k from 17.1 ± 1.3 to 19.4 ± 1.5, n=9; Fig.40 D, right curves). AA shifted 
the voltage dependence of steady-state inactivation of Kv1.4-encoded channels from -66.2 ± 
2.6 mV to -75.5 ± 2.1 mV (k from 19.6 ± 2.2 to 22.6 ± 1.9, n=9; Fig.40 D, right curves), but 
did not affected IA -inactivation kinetic (τi =52.8 ± 2.8ms to 49.4 ± 2.4ms). 
 
Influence of Trolox on arachidonic acid-mediated effects 
To examine possible involvement of free radicals in the AA effect on Kv1.4 α-current, the 
water-soluble analogue of Vit.E, Trolox C was applied. Co-application of 10 µM Trolox with 
AA to the pipette solution did not significantly block the effect of 1pM AA on the maximal 
amplitude of Kv1.4 currents (-64.8 ± 7.9 % vs. -71.4 ± 6.3 %; Fig.41 C). Troloxin+AA caused 
a large leftward shift of the voltage-dependence of IA activation (V50a from -5.6 ± 1.3 mV to -
37.1 ± 1.8 mV, n=9), as well as slope factor change from 18.1 ± 1.2 to 12.8 ± 1.6 (Fig.41 D, 
right curves). Under these conditions (AA+Troloxin) voltage dependence of the steady-state 
inactivation remained unchanged (Fig.41 D, left curves). Trolox C, applied intracellularly, 
slowed down the rate of inactivation of Kv1.4 channels (from τi=34.3 ± 2.9 ms to τi =47.9 ± 
3.2 ms). 
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Fig. 41 Interaction of AA and Troloxin with IA in Kv1.4-transfected HEK-293 cells.  
A, B: Intracellular application of the vitamin E analogue Trolox (10 µM) does not prevent reduction of 
IA by arachidonic acid. C: Intracellular application of Trolox and AA reduces IA similar to 1 pM AA 
(blue line). D: In the presence of Trolox on the inner side of the cell membrane, AA shifts activation 
kinetic of IA by 30 mV to more negative potential over 900 s recording time (right curves). There was 
no shift in voltage dependence of steady-state inactivation (left curves). 
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Fig. 42 Interaction of AA and Troloxout with IA in Kv1.4-transfected HEK-293 cells.  
A, B: Original traces for activation (A) and inactivation (B) of transient potassium current 
prior to (0 s) and after (900 s) application of AA+Troloxin/out. Protocols: inset in A2, B2. C: 
Trolox, applied from both sides of the cell membrane (green line), did significantly recover IA 
from 1 pM AA (red line). D: No shift of activation or steady-state inactivation occurs after 
intra- and extracellular application of Trolox and AA.  
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When applied on the both sides of the HEK cell membrane, Trolox reduced significantly  
(-31.2 ± 6.1 %, n=6) the effect of 1 pM arachidonic acid (-71.4 ± 6.3 %, n=9) on the maximal 
amplitude of the Kv1.4-induced currents (Fig.42 C). Trolox, applied simultaneously through 
the pipette and the bath solutions, did not alter Kv1.4 channel characteristics as voltage 
dependences of activation and steady-state inactivation, slope factors or rate of inactivation 
(Fig.42 D). 
 
Modulation of transient potassium current by arachidonic acid and Trolox 
in heterologously expressed Kv4.2-α in HEK-293 cell line 
Transient potassium current in untreated Kv4.2-transfected HEK-293 cells 
Transfection of Kv4.2 α-subunit in HEK-293 cells resulted in expression of robust outward 
current with amplitude at +30 mV of 2 to 8 nA (Fig.42 A, B). Kv4.2 current characteristics as 
maximal amplitude voltage dependences of activation and inactivation did not change 
significantly over the recording time of 15 min. (Fig.43 C, D, Table 11). 
 
Modulation of transient potassium current by AA in Kv4.2-transfected HEK-293 
cells 
Fig.44 shows the effect of 1pM arachidonic acid observed as 54.7 ± 6.9 % (n=12) reduction of 
the maximum amplitude of the Kv4.2-encoded current, measured at +30 mV. The inhibition 
of the Kv4.2 currents by AA was accompanied by a modest (~3 mV) shift in depolarizing 
direction of the voltage-conductance relation of Kv4.2 channel inactivation (Fig.44 D, left 
curves). No changes in voltage dependence of activation or time course of inactivation of 
Kv4.2 channels were observed after intracellular application of 1 pM AA (Fig.44 A, D; Table 
11). 
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Fig. 43 Transient potassium current in Kv4.2-transfected HEK-293 cells. 
A, B: Original traces showing IA activation (A) and inactivation (B) at 0 s (1) and 900 s (2) of 
recording. Pulse protocols: inset A2, B2. C: Transient potassium current (IA) recorded at +30 mV over 
time in control condition. D: Voltage-conductance dependence of activation (right curves) and steady-
state inactivation (left curves) of IA at 0 s and 900 s after opening the cell. 
 
 89 
 
 
    0s    AA
 900s    AA
B2 
B1 
4 nA 
100 ms 
D 
-100 -50 0 50
0.0
0.5
1.0
                                              mV
   
   
   
   
g/
g m
ax [AA]i  
control
C 
0 180 360 540 720 900
0
50
100
                                            time, s
   
   
   
   
I A
, %
[AA]i  
control
A1 
A2 
 
 
Fig. 44 Suppression of Kv4.2- IA by arachidonic acid (AA).  
A, B: Control activation (A1) and inactivation (B1) of IA. Raw current traces of IA are shown for 
control immediately after obtaining whole cell configuration (A1, B1, 0 s AA) and after 900 s of 
recording with 1 pM of AA in the patch pipette (A2, B2, 900 s AA). Pulse protocols: inset A2, B2. C: 
Intracellular application of 1 pM AA (red line) reduces the maximal transient potassium current (IA) 
over time. D: Activation (left curves) and steady-state inactivation (right curves) kinetics in control 
condition (black symbols) and after application of 1 pM arachidonic acid through the pipette (red 
symbols). 
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Influence of Trolox on arachidonic acid-mediated effects 
Again, Trolox C that showed the greatest potency as antioxidant in experiments with CA1, 
ECLII and III neurons, was used in Kv4.2–transfected HEK-293 cells to test the hypothesis 
that AA modulates the A-current through an oxidative mechanism. 
Trolox failed to block the effect of 1 pM arachidonic acid on the maximal Kv4.2 current when 
applied to the pipette solution (-63.3 ± 7.1 %, vs. -54.4 ± 6.9 %; Fig.45 C). Intracellular 
Trolox had effect neither on the voltage dependence, nor on the time course of Kv4.2-current 
inactivation (Fig.45 B; D, left curves). In the presence of Trolox inside the cell V50 of Kv4.2-
current inactivation was shifted from -82.5 ± 1.7 mV to -87.6 ± 1.0 mV and the slope factor 
changed from 17.5 ± 1.6 to 12.8 ± 0.9 (Fig.45 D, left curves).  
As observed in Kv1.4-transfected HEK-293 cells, Trolox applied both through the pipette and 
the bath significantly attenuated the effect of 1 pM AA on the maximal conductance of Kv4.2 
channels (-24.8 ± 7.4 % vs. -54.7 ± 6.9 %; Fig.46 C).  
Trolox, applied to the both sides of the cell membrane dramatically affected Kv4.2 activation 
by shifting its voltage dependence to depolarizing direction from -25.7 ± 1.8 mV to 7.2 ± 0.6 
mV (n=7) and altering its slope factor from 17.8 ± 1.7 to 13.1 ± 0.5 (Fig.46 D, right curves).  
On the other hand, no effects of Trolox in/out +AA on Kv4.2-current time constant or voltage 
dependence of steady-state inactivation were observed (Fig.46 B, D, left curves, Table 11).  
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Fig. 45 Interaction of AA and Troloxin with IA in Kv4.2-transfected HEK-293 cells. 
 A, B: Intracellular application of the vitamin E analogue Trolox (10 µM) with AA has similar effect 
on IA as AA only (red line). Original traces for activation (A1, A2) and inactivation (B1, B2), 
immediately after obtaining whole-cell configuration (0 s, A1, B1) and after 900 s of recording (A2, 
B2). Protocols: inset A2 and B2. C: Intracellular Trolox (blue line) did not inhibit the AA-induced 
reduction of the maximal IA amplitude (red line) over time. D: In the presence of Trolox on the inner 
side of the membrane plus AAi (blue symbols), no significant changes in activation (right curves) and 
inactivation (left curves) kinetics occur in comparison to control activation and inactivation kinetics 
(black symbols). 
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Fig. 46 Interaction of AA and Troloxout with IA in Kv4.2-transfected HEK-293 cells.  
A, B: Raw current traces for activation (A) and inactivation (B) of transient potassium current prior to 
(0 s) and after (900 s) application of AA+Troloxin/out. Protocols: inset in A2, B2. C: Trolox, applied 
from both sides of the cell membrane (green line), did significantly recover IA from 1 pM AA (red 
line). D: Intra- and extracellular application of Trolox (green symbols), together with AAi, causes a 30 
mV shift to more positive direction of IA activation (right curves), but does not affect its steady-state 
inactivation (left curves). 
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Table 11 Overview of effects of oxidants and antioxidants on behavior parameters of 
IA in HEK-293 cells, transfected with Kv1.4 and Kv4.2. 
 
 
I A   Kv1.4 
 
n 
max 
amplitude,
% of 
control 
V 50a 
0 min  
mV 
V 50a 
15 min  
mV 
kactivation 
0 min 
ka 
15 min 
V 50i 
0 min
mV 
V 50i 
15 min
mV 
kinactivation 
0 min 
ki 
15 min 
τi 
0 min  
ms 
τi 
15 min 
ms 
Control 7 
 
-12.1±6.1% 
 
-24.7±2.4 
 
-4.8±1.8 
 
23.8±2.3 
 
20.0±1.6 
 
-70.0±2.1
 
-68.3±1.7
 
17.6±1.9 
 
17.0±1.5 
 
51.7±2.9 
 
52.9±2.8 
 
+ 1pM AA 9 
 
-71.4±6.3% 
 
-9.2±1.4 
 
-5.2±1.6 
 
17.1±1.3 
 
19.4±1.5 
 
-66.2±2.6
 
-75.5±2.1
 
19.6±2.2 
 
22.6±1.9 
 
52.8±2.8 
 
49.4±2.4 
 
AA+Troloxin 9 
 
-64.8±7.9% 
 
-5.6±1.3 
 
-37.1±1.8
 
18.1±1.2 
 
12.8±1.6 
 
-73.1±2.6
 
-75.6±2.0
 
20.6±2.4 
 
21.7±1.9 
 
34.3±2.9 
 
47.9±3.2 
 
AA+Troloxin, 
out 
6 
 
-31.2±6.1% 
 
-19.4±1.8 
 
-23.6±2.0
 
17.2±1.6 
 
17.2±1.8 
 
-62.4±2.2
 
-60.6±1.8
 
14.0±1.9 
 
13.5±1.6 
 
67.4±4.8 
 
75.9±3.9 
 
I A   Kv4.2             
Control 6 
 
-9.9±7.6% 
 
-42.0±2.9 
 
-42.9±2.4
 
18.4±2.7 
 
16.6±2.2 
 
-73.6±0.6
 
-68.8±0.7
 
7.1±0.5 
 
7.3±0.6 
 
35.6±3.9 
 
32.5±3.6 
 
+ 1pM AA 12 
 
-54.7±6.9% 
 
5.5±1.1 
 
8.4±1.0 
 
15.9±1.0 
 
15.8±0.9 
 
-62.2±0.8
 
-56.6±1.4
 
11.6±0.7 
 
10.5±1.2 
 
27.2±4.1 
 
25.2±3.9 
 
AA+Troloxin 4 
 
-63.3±7.1% 
 
-5.9±1.4 
 
-1.3±0.8 
 
17.9±1.3 
 
17.5±0.7 
 
-82.5±1.7
 
-87.6±1.0
 
17.5±1.6 
 
12.8±0.9 
 
41.3±3.4 
 
37.4±3.7 
 
AA+Troloxin, 
out 
7 
 
-24.8±7.4% 
 
-25.7±1.8 
 
7.2±0.6 
 
17.8±1.7 
 
13.1±0.5 
 
-31.5±2.8
 
-30.6±3.7
 
19.0±2.5 
 
16.3±3.3 
 
24.5±4.8 
 
25.6±4.6 
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DISCUSSION 
Effect of arachidonic acid on the transient potassium current 
In the present study, an ultra low patch pipette concentration of AA (1 pM) consistently 
inhibited the maximal conductance of the transient K+ current IA in all studied preparations. 
In CA1 pyramidal neurons intracellular arachidonic acid reduced the maximal conductance of 
the transient potassium current IA by about 45 %, while not affecting the delayed rectifier 
current Ik(v). The effect of arachidonic acid develops over 15 min of dialysis in agreement with 
diffusional exchange between the patch pipette and soma ⁄ proximal dendrites of a CA1 
pyramidal neuron (Pusch and Neher, 1988). ETYA, a non-metabolizable analogue of AA 
requires higher concentration (100 pM) to mimic the effect of 1 pM arachidonic acid. This 
may probably be due to substitution of the four highly reactive double carbon bonds of AA 
with the much more stable triple bonds of ETYA. Higher concentration is also probably the 
reason for the effect of ETYA to develop faster in comparison to those of AA. As ETYA 
inhibits the AA-metabolizing enzymes cyclooxygenase, lipoxygenase and cytochrome P450, 
these results suggest a direct specific effect of AA (1 pM) or ETYA (100 pM) on IA. “Direct” 
should be understood as effect that is not exerted by AA metabolites and should not exclude 
the possibility that AA effects could be mediated by other processes or intermediate 
compounds, e.g. ROS production, altered redox potential or membrane fluidity. 
The effect of 1 pM AA on the maximal conductance of IA is stronger in neurons from the 
entorhinal cortex, where IA was suppressed by 60-70 %.  
1 pM AA affects clearly the inactivation of the A-channels. In addition to the reduction of the 
maximal conduction of IA, AA causes a significant shift (~12 mV) of steady-state inactivation 
to more negative potentials in hippocampal, as well as entorhinal cortex neurons. This will 
correspond to a decrease in the probability of the channels to be found in open state at certain 
test voltage. 
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Thus, AA shift will cause further reduction of IA by 10–40% when IA is activated from a 
membrane potential of -60 to -50 mV. Actually, in neurons the transient potassium current IA 
is comprised by Kv1.4 and Kv4.2 that belong to different gene subfamilies and the channels 
they form exhibit different types of inactivation. HEK-293 cell lines were transfected 
separately with cDNAs, coding only the pore-forming subunits of those channels. 
Interestingly, the effect of 1 pM AA on the maximal conductance was still present. IA was 
reduced by ~ 70% in Kv1.4- and by ~ 55 % in Kv4.2-transfected HEK cells. There is, at first 
sight, a contradiction of the findings that Kv1.4 (Shal family) channel shows insensibility to 
25 µM AA in Xenopus oocytes (Villarroel and Schwarz, 1996) and above presented results. In 
fact, it is already known, that the same channels in different expression systems may exhibit 
different values for time- and voltage-dependence or drug effects. It has been shown, for 
example, that kinetic properties of Kv 4.2- and Kv1.4-evoked currents depend strongly on the 
expression environment in experiment comparing ventricular myocytes, oocytes and HEK-
293 cell lines (Petersen and Nerbonne, 1999). Additionally, some members of Shaw family 
also encode A-type currents albeit with lower 4-AP sensitivity. Products of Kv3.1 and Kv3.2 
genes express delayed-rectifier type currents in heterologous expression systems, while Kv 
3.3 and Kv3.4 proteins express A-type currents. However, Kv3.3 currents, which are also 
transient when expressed in oocytes, resemble Kv3.1 and Kv3.2 currents when expressed in 
CHO or HEK-293 cells (Rudy et al., 1999).  
It must be noted that Kv1.4- and Kv4.2-elicited currents have some similarities with native 
currents, but in general possess quantitatively distinct properties, concerning time- and 
voltage-dependence. As observed by the present and other studies (Villarroel and Schwarz, 
1996; Holmqvist et al., 2001), in different non-neuronal expression systems the reduction of 
the Kv-α-currents maximal amplitude by arachidonic acid isn’t accompanied by kinetic 
changes.  
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One can assume that this is due to absence of important auxiliary subunits and/or cytosol 
factors in the expression model system. In agreement, Kv1.4-transfetced HEK-293 cells 
exhibited A-type current with distorted inactivation in control conditions. 
In addition, both Kv1.4 and Kv4.2 current inactivation is significantly slower compared to 
neuronal A-current. Moreover, in my study, the Kv-α-evoked currents inactivation in HEK 
293 cells is in general insensitive to arachidonic acid. Taken together with the strong 
reduction of the maximal conductance of Kv-α-currents by 1 pM AA, one can hypothesize 
that there are at least two action sites for arachidonic acid to modulate A-channels and at least 
one of them is situated on or in the vicinity of the α-subunits. It can be also concluded that 
neuronal regulatory subunits are necessary for AA effect. Holmqvist et al, 2001, found out 
that KChIP1 is required for Kv4 current modulation by 10 µM arachidonic acid in Chinese 
hamster ovary (CHO) cells and Xenopus oocytes.  
 
Oxidation is involved in arachidonic acid-mediated modulation of the A-
current 
Rationale for studying the oxidation as a mediating process for arachidonic acid modulation 
of potassium channels was its photo- and air-sensitivity. Unsaturated fatty acids are highly 
susceptible to oxidative breakdown (Frankel, 1984). PUFAs can autooxidize to form 
hydroperoxide, carbon or cyclic peroxy radicals. Therefore some researchers add ascorbic 
acid to protect arachidonic acid in solution from autooxidation. Further motivation was the 
fact that the concentration of arachidonic acid in effectively suppressing transient potassium 
current in my experiments is 1 pM. This extremely low concentration supposes very specific 
arachidonic acid-channel protein interaction or alternatively, an amplifying reaction, which 
would be in this case a radical chain reaction. 
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Moreover, oxidative stress is emerging as a cause and consequence of several 
neurodegenerative diseases, including Alzheimer’s disease, temporal lobe epilepsy, 
Parkinson’s disease, etc. Entorhinal cortex shows neuronal loss early in AD (layer II) and 
TLE (layer III). CA1 neurons from the hippocampus are damaged late in both diseases. 
Therefore, in this study the susceptibility of A-type potassium current to oxidative modulation 
in ECLII stellate cells, ECLIII and CA1 pyramidal neurons was compared. A-currents from 
the entorhinal cortex neurons are more sensitive to 1 pM AA.  
Moreover, studies with antioxidants conclude involvement of oxidation in arachidonic acid 
effects. Both of the described AA effects, reduction of maximal conductance and shift of 
steady-state inactivation, are independently affected by GSH, ascorbic acid, Trolox and H2O2. 
These results further support the hypothesis that the effects of AA are mediated by at least 
two oxidation sites of the channel protein. The oxidation sites are most likely intracellular; as 
intracellular AA and membrane-impermeable antioxidants (Trolox, GSH) applied from the 
inside have strong effects. Surprisingly, intracellular application of 20 mM GSH did not block 
the effect of AA in CA1, ECLIII and ECLII neurons from brain slice, as reported for 
hippocampal neurons in primary culture (Bittner and Muller, 1999; Muller and Bittner, 2002), 
but strongly enhanced it, particularly at 3 min of whole-cell recording. In contrast, 
combination of GSHi with extracellular application of ascorbic acid (0.4 mM) significantly 
inhibited the reduction of IA by AA in CA1 pyramidal neurons, but not in neurons from the 
entorhinal cortex. Shift of steady-state inactivation to more negative potentials was not 
affected by GSHi or by the combination of GSHi and ascorbic acid in CA1 or ECLII neurons, 
but was blocked in ECLIII pyramidal neurons. Additionally, GSH and ascorbic acid affected 
voltage dependence of activation in neurons from acute slice. Enhancement of the AA effect 
by some antioxidants may be mediated by catalysing the underlying reactions between AA 
and other radicals in the slice tissue and channel protein.  
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Antioxidants have some capacity to buffer oxidants but in this process they themselves 
become oxidants that may, in turn, more effectively oxidize certain targets. For example, GSH 
reductase becomes oxidized by the reduction of GSSG to GSH and, in turn, is reduced by 
oxidizing NADP+ to NADPH, thereby acting as a catalyst of the reaction between NADP+ and 
GSSG. 
Very interesting and important finding of this study is the reduction of the transient and the 
delayed rectifier currents by antioxidants. In CA1 pyramidal neurons, GSHin did not affected 
the maximal amplitudes of these currents, but shifted the voltage-conductance dependence in 
AA-similar way. Ascorbic acidout in turn dramatically suppressed IA and IK(V) amplitudes, 
without affecting their voltage dependences of activation and inactivation. This suggests that 
potassium channels can sense redox changes. 
Trolox applied from the inside blocks the reduction of the maximal amplitude of IA by AA 
only in ECLIII pyramidal neurons, but abolishes AA effect on the voltage-conductance 
dependence inactivation in CA1 and ECLII neurons. In these two types of neurons Troloxin 
had the same enhancing influence on AA effect as GSH. Interestingly, intracellular Trolox by 
itself reduced IA in CA1 pyramidal neurons and produced AA-similar shift of inactivation 
voltage-dependence. On the other hand, Trolox applied both inside and outside of the 
membrane significantly recover the AA-mediated reduction of IA with prolonged recording 
time only in CA1 pyramidal neurons. Additionally, Trolox in/out completely block the effect of 
arachidonic acid on the maximal conductance of Kv1.4 and Kv4.2 channels. This further 
supports the reduction of maximal IA conductance and shift of steady-state inactivation being 
independent modifications of the channel protein. Reduction of superoxide anions to H2O2 by 
superoxide dismutase gives an electroneutral molecule that much better permeates into lipid 
membranes (Nelson and Cox, 2005). Oxidation of channel proteins may be facilitated by 
antioxidants in a similar way. Such a view is further supported by the effects of H2O2 on IA. 
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H2O2 as a model oxidative modulation of ion channels 
Intracellular application of H2O2 reduced IA more effectively than AA in CA1 pyramidal 
neurons, but to the same extent as AA in neurons from the entorhinal cortex.  
Furthermore, H2O2 strongly reduced IK(V) in CA1 neurons. It has been shown that H2O2 dose-
dependently enhances the cell membrane associated PLA2 activity and stimulates AA-release 
(Chakraborti and Michael, 1993; Yasuda et al., 1999). Therefore, it is possible that the 
stronger effect of H2O2 is due to stimulating of AA release that in turn additionally reduces 
the A-current. The effect of H2O2 on the maximal conductance was abolished by antioxidants 
only in CA1 pyramidal neurons, whereas entorhinal cortex neurons showed no recovery. 
On the other hand H2O2 shifted voltage-dependence of inactivation to the same extent as AA.  
Unlike AA, H2O2 also reduced the maximal conductance of the delayed rectifier current IK(V) 
in a GSHi-sensitive way, further supporting that the interaction of AA with IA is highly 
specific.  
 
Culture vs. Slices  
The reduction of IA by extremely low concentrations of intracellular arachidonic acid or by 
H2O2 is in agreement with experiments, conducted with cultured hippocampal neurons 
(Bittner and Muller, 1999; Muller and Bittner, 2002). Therefore, it was expected antioxidants 
to block arachidonic acid effects in acute slices, as it was reported for neurons from primary 
hippocampal culture (Bittner and Muller, 1999; Muller and Bittner, 2002). Unexpectedly, 
enhancement and acceleration of arachidonic acid effect by several antioxidative agents in 
brain slice were observed. This suggests fundamental differences of oxidative regulation of 
the A-current and Ikv in cultured hippocampal neurons, compared to neurons from brain slice.  
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It is possible that GSH is oxidized to GSSG that, in turn, more effectively oxidizes cystein, 
methionine or histidine residues in the channel protein that are not accessible to GSSG in 
cultured neurons because of subunit composition or differential expression of other interacting 
proteins. This may have implications for the relevance of excitotoxicity and oxidative stress 
research using neuronal cultures. 
Neuronal cultures are criticized for abnormal neuronal behaviour that may result from 
developmental maturation under artificial conditions, leading many to favour acute brain slice 
preparations or in vivo recording. For example, inhibitory synapses in dissociated neuronal 
cultures exhibit abnormal physiology from postnatal day 6–15, continuing to show properties 
of early (postnatal day 1–5) postnatal synapses even after 13–21 days in vitro (Henneberger et 
al., 2005). Cortical oscillatory behaviour in vivo does not require GABA A-ergic transmission 
and disappears at postnatal day 6–7 (Garaschuk et al., 2000), but develops much more slowly 
in cortical cultures only after days 9–15 in vitro and requires GABAA receptor activation 
(Opitz et al., 2002).  
In one hand, brain slices are usually maintained in a 95% O2 atmosphere in order to avoid O2-
dependent cell damage at a depth of 90–150 μm below both surfaces of the slice, as observed 
for an interface slice configuration at 20% O2 with histology (Bingmann and Kolde, 1982). 
On the other hand, in experiments concerning oxidative modulation of channel in brain slice 
neurons, 95% O2 is an important issue. Actually, with an O2 partial pressure of 600 mmHg 
(79%) in the perfusion, microelectrode measurements have shown steep gradients of O2 
partial pressure in the bath adjacent to the slice surface, with an O2 pressure gradient inside 
brain tissue of 400-µm slices at 24°C from 60 to 15 mmHg, i.e. in a normal physiological 
range for neurons only 50 µm below the surface and a hypoxic range in the centre of the slice, 
with observations of vacuolization of cytoplasm even in 300-μm-thick slices (Bingmann and 
Kolde, 1982).  
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The work of Bingmann and Kolde (1982), comprising data from 300–1000-μm thick slices at 
temperatures from 24 to 35 °C, shows somewhat lower O2 pressure at the submerged side of 
slices in comparison to the gas interface side, indicating even less efficient O2 supply in the 
submerged configuration. In order to avoid tissue hypoxia, recordings from submerged slices 
are usually performed at temperatures of 24–32°C, significantly below 37°C (Colbert and 
Pan, 1999; Garaschuk et al., 2000; Henneberger et al., 2005). This appears to be essential for 
healthy brain slice electrophysiology and histology, typically showing excellent agreement 
with in vivo findings. 
 
Role of membrane fluidity 
Lipid molecules surround an ion channel in its native environment of cellular membranes. 
However, the importance of the lipid bilayer and the role of lipid/protein interactions in ion 
channel structure and function are not well understood. Rod MacKinnon group the presence 
of negatively charged lipids is required for ion conduction through the potassium channel, 
suggesting that the lipid bound to the channel protein is important for ion channel function 
(Valiyaveetil et al., 2002). They also recently demonstrated that the bacterial potassium 
channel KcsA binds a negatively charged lipid molecule and that lipids are required for the in 
vitro refolding of the channel tetramer from the unfolded monomeric state.  
Moreover, in my experiments Trolox, that is known to be a potent antioxidant against lipid 
peroxidation, had the strongest effects in reduction of AA-induced reduction of IA, 
particularly when applied on both sides of the membrane. Therefore, it is not excluded that 
arachidonic acid/ROS influence channel protein functions through changing annular and/or 
bulk fluidity of the membrane, although the hypothesis that arachidonic acid may affect Kv 
channels in oocytes by affecting the membrane fluidity was rejected by Villaroel and Schwarz 
in 1996 (Villarroel and Schwarz, 1996).  
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Arachidonic acid as a retrograde messenger 
The participation of arachidonic acid and its metabolites in retrograde signaling and in other 
forms of local modulation of neuronal activity has been proposed (Kandel and O'Dell, 1992; 
Williams et al., 1989). It is well known that stimulation of glutamate receptors evokes 
arachidonic acid release in a variety of neural cell preparations. In agreement to that, 
nonselective PLA2 inhibitors prevent induction of LTP, while application of arachidonic acid 
(or other unsaturated fatty acids) to hippocampal slices causes a slow-onset enhancement of 
synaptic transmission that resembles LTP. It is known that the fatty acid may increase 
glutamate release from hippocampal nerve terminals, block glutamate uptake, or potentiate 
NMDA receptor current (Freeman et al., 1990). Alternatively, it may act by enabling 
presynaptic glutamate receptors to produce enhanced glutamate release. After the discovery of 
the prostaglandins (PGs) in the CNS, much attention has been given to the role the 
eicosanoids may play in modulating neurotransmission, by interacting with presynaptic or 
with postsynaptic PG receptors. The existence of such receptors is well-demonstrated, and, in 
the brain, high-affinity binding sites have been described for both PGE2 and PGD2 (Yumoto 
et al., 1986). 
On one hand, direct AA retrograde messaging is most likely not an issue, as the applied 
concentration of AA is extremely low (1 pM) and apparently not sufficient for building a 
gradient, that could facilitate AA diffusion through the neuronal membrane. On the other 
hand, various enzymes stay alert for immediate conversion of AA to one of its many 
metabolites, which had also been shown to play some role in induction of LTP. 
1 pM AA most probably exert effects on synaptic transmission by attenuating the maximal 
conductance and diminishing the number of open A-type channels. 
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Kv4.2 and Kv1.4 are known to be substrates for all 4 enzymes, which participate in LTP: 
PKA, PKC, CaMKII and erk MAPK. On one hand, arachidonic acid can stimulate MAPK, 
probably through PKC (Hii et al., 1995). On the other hand it has been shown, that ROS could 
activate erk-s (Baas and Berk, 1995) and PKC (Gopalakrishna and Anderson, 1989). It is not 
excluded, that arachidonic acid modulates phosphorylation of channel proteins by these 
kinases via ROS production. However, the exact role of arachidonic acid in enhancing 
neurotransmission remains to be established. If AA is released in presynaptic terminals and 
suppresses IA then Ca2+ influx into presnypatic terminals may be augmented and transmitter 
release subsequently increased. Expression of IA has been described for mossy fiber terminals 
in CA3 and 4-AP has a strong effect on presynaptic Ca2+ uptake and on glutamate release. 
 
Significance of potassium channel modulation by ROS 
Oxidation-derived radical species were once considered to be metabolic by-products that have 
mostly negative function. In continuously growing body of evidence, ROS are recognized to 
have roles in cell signalling and to take part in number of cellular functions, such as O2 
sensing, cell proliferation, and apoptosis (Schafer and Buettner, 2001). Numerous K+-
channels and other transport mechanisms are in fact redox-regulated (Kourie, 1998). Redox 
response of K+-channels may be a regulation mechanism to changes in the cellular 
metabolism.  
Oxidizing and reducing agents produce functional changes, mostly of the channel protein 
itself. Typically, the gating characteristics are altered while the permeation properties remain 
largely unchanged.  
Furthermore, each channel complex may contain multiple oxidation targets that determine the 
effect specificity. It is possible that different experimental reagents attack distinct target 
residues. 
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For example, cysteine oxidation decreases the overall channel activity by decreasing the 
number of channels available to open by driving the channels to a very long-lived closed state 
(Soto et al., 2002). Additional complexity in the oxidant sensitivity of K+-channel is conferred 
by oxidation of methionine residues. Reversible oxidation of methionine has been suggested 
to play a role both as a regulatory mechanism and also as an endogenous oxidant scavenger 
system (Hoshi and Heinemann, 2001). 
The pore-forming subunits Kv1.4 and Kv4.2 contain many different situated cysteine and 
methionine residues, and differential oxidation of these residues in HEK-293 cells may 
account for the diverse results reported here.  
Oxidative regulation is also reported for many Kv channels both in native and heterologous 
systems (Rozanski and Xu, 2002). N-type inactivation of Kv1.4 is reversibly redox-modulated 
by means of a cysteine in the distal part of the N-terminal inactivating ball domain 
(Ruppersberg et al., 1991). Auxiliary subunits which specifically co-assemble with Kv-α, also 
provide cysteine-containing N-terminal ball domains to equip Kv-α with redox-dependent 
inactivation. Potentially, this may allow for greater precision in regulation, as thus metabolic 
and electric events are coupled. Still, experimental evidence to support this idea is not yet 
available.  
 
Arachidonic acid, oxidative stress and neurodegenerative diseases 
Oxidative stress has met continuously growing interest for its roles in the physiology and 
pathophysiology of immune defense, ischemia, and neurodegenerative disease. Reactive 
oxygen species modify ion channels and other transport mechanisms (Kourie, 1998). 
In this study, entorhinal cortex (EC) layer II stellate neurons (that show neuronal loss early in 
AD) and layer III pyramidal neurons (are shown to be damaged early in TLE) are compared 
to hippocampal CA1 pyramidal neurons (that are damaged late in TLE and AD). 
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Furthermore, the present study supported the finding that antioxidants in particular cases 
could affect ion channel functions alone or by increasing the AA-induced reduction. Clearly, 
AA as well as H2O2, particularly in older age or in neurodegenerative disease (Auerbach and 
Segal, 1997), will strongly affect K+-currents and, via depolarization and inactivation of Na+-
channels, dendritic excitability and spike-timing-dependent synaptic plasticity / learning 
(Giese et al., 1998). Antioxidative therapy as a part of neurodegenerative condition treatment 
program may then have negative effects in this context.  
 
Mechanism of arachidonic acid modulation of Kv channels still remain to 
be discovered 
Members from the same Kv families can co-assemble to form functional channels. 
Functionally, this has crucial implications for both physiology and pharmacology of the final 
K+-channel expressed in the cell membrane. Therefore, one must exercise considerable 
caution when extrapolating data for a single channel subunit to a “real” channel in a “real” 
cell membrane. The complexity increases further, as K+-channels can associate with a large 
number of 'accessory subunits', which can alter the properties of the resulting oligomeric 
channel even more.  
Indeed, the total number of different subunits is even larger since many of the subunit genes 
undergo RNA processing, such as alternative splicing resulting in multiple protein products 
from each gene. Additionally, the diversity of K+ channels is magnified by alternative 
splicing, RNA editing and posttranslational modifications (Coetzee et al., 1999).  
A difficult question that is yet to be addressed adequately is where and how arachidonic acid 
and/or ROS could modulate Kv channel function. 
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CONCLUSION 
Novel findings 
The present study was undertaken to investigate the mechanism of modulation of transient 
potassium channels by arachidonic acid and possible involvement/contribution of free radicals 
to this process. Based on the presented results, the following novel findings could be briefly 
summarized as: 
1) The transient potassium current (IA) is extremely sensitive to intracellular arachidonic acid 
in neurons from acute slices. 1 pM AA was sufficient to reduce A-current by about 50 % in 
CA1 pyramidal neurons, by ~60 % in ELCIII pyramidal neurons and Kv4.2-transfected 
HEK293 cells, and by ~70% in ECLII stellate cells and Kv1.4-transfected HEK 293 cells. 
2) The effect of AA on the transient potassium currents in ECLII stellate neurons, ECLIII 
pyramidal neurons and CA1 pyramidal neurons is mimicked by the polyunsaturated fatty acid 
ETYA. However, ETYA required 100-fold higher concentration. 3) The delayed rectifier 
current is in general (with exception of ECLII neurons) insensitive to 1 pM arachidonic acid. 
4) AA-mediated modulation of IA involves ROS formation, as some of the AA effects are 
blocked by antioxidants. 5) Existence of more than one modulation sites for arachidonic acid 
and H2O2 on potassium channel complex molecules is possible. 6) Neurons from the 
entorhinal cortex (LII and LIII) tend to be more sensitive to oxidative stress than CA1 
pyramidal neurons. 7) Both delayed rectifier and transient potassium channels reacted to 
exogenously applied H2O2 with strong reduction of their conductivity. 8) In contrast to 
primary cultured neurons, H2O2 effects in acute brain slices were not always abolished by 
antioxidants, which reveal different mechanisms in current modulation in neurons from acute 
brain slices compared to neurons in culture. 9) Antioxidants by themselves may affect 
functionality of potassium channels. 
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Significance 
The results from this study provided evidence that endogenously generated free radical 
processes contribute significantly to the regulation of Kv channels in entorhinal cortex and the 
hippocampus. 
 
Outlook 
The functional properties of many Kv channels are clearly altered by oxidizing and reducing 
treatments. How these oxidative modifications contribute to neuron and other cell function 
needs to be investigated. The results presented in this study, together with the recent findings 
in the field suggested, that we are just at the beginning of the revolution of the ROS-and O2-
signalling research that may shed light not only on normal biological functions of the brain, 
but on disease mechanisms that are so far poorly understood, as Alzheimer’s, Parkinson’s, 
schizophrenia, etc. Future research should focus on: 1) discovering molecular, physiological 
and pharmacological features of missing key elements of the functional channels; 2) their 
precise cellular and subcellular localization ; 3) biochemical machinery involved in channel 
modulation; 4) roles played by ROS in channel modulation in various neurological and 
psychiatric disorders; 5) novel ROS signalling pathways. 
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